Coactivation	O
by	O
OCA-B	B-protein
:	O
definition	O
of	O
critical	O
regions	O
and	O
synergism	O
with	O
general	O
cofactors	O
.	O

Molecular	O
dissection	O
of	O
the	O
B-cell-specific	O
transcription	O
coactivator	O
OCA-B	B-protein
has	O
revealed	O
distinct	O
regions	O
important	O
,	O
respectively	O
,	O
for	O
recruitment	O
to	O
immunoglobulin	B-DNA
promoters	I-DNA
through	O
interaction	O
with	O
octamer-bound	B-protein
Oct-1	I-protein
and	O
for	O
subsequent	O
coactivator	O
function	O
.	O

Further	O
analysis	O
of	O
general	O
coactivator	O
requirements	O
showed	O
that	O
selective	O
removal	O
of	O
PC4	B-protein
from	O
the	O
essential	O
USA	O
fraction	O
severely	O
impairs	O
Oct-1	O
and	O
OCA-B	O
function	O
in	O
a	O
cell-free	O
system	O
reconstituted	O
with	O
partially	O
purified	O
factors	O
.	O

Full	O
activity	O
can	O
be	O
restored	O
by	O
the	O
combined	O
action	O
of	O
recombinant	O
PC4	B-protein
and	O
the	O
PC4	B-protein
-depleted	O
USA	O
fraction	O
,	O
thus	O
suggesting	O
a	O
joint	O
requirement	O
for	O
PC4	B-protein
and	O
another	O
,	O
USA-derived	O
component	O
(	O
s	O
)	O
for	O
optimal	O
function	O
of	O
Oct-1	B-protein
/OCA-B	B-protein
in	O
the	O
reconstituted	O
system	O
.	O

Indeed	O
,	O
USA-derived	B-protein
PC2	I-protein
was	O
found	O
to	O
act	O
synergistically	O
with	O
PC4	B-protein
in	O
reproducing	O
the	O
function	O
of	O
intact	O
USA	O
in	O
the	O
assay	O
system	O
.	O

Consistent	O
with	O
the	O
requirement	O
for	O
PC4	B-protein
in	O
the	O
reconstituted	O
system	O
,	O
OCA-B	B-protein
was	O
found	O
to	O
interact	O
directly	O
with	O
PC4	B-protein
.	O

Surprisingly	O
,	O
however	O
,	O
removal	O
of	O
PC4	B-protein
from	O
the	O
unfractionated	O
nuclear	O
extract	O
has	O
no	O
detrimental	O
effect	O
on	O
OCA-B	B-protein
/	O
Oct-1	B-protein
-dependent	O
transcription	O
.	O

These	O
results	O
lead	O
to	O
a	O
general	O
model	O
for	O
the	O
synergistic	O
function	O
of	O
activation	O
domains	O
in	O
Oct-1	B-protein
and	O
OCA-B	B-protein
(	O
mediated	O
by	O
the	O
combined	O
action	O
of	O
the	O
multiple	O
USA	O
components	O
)	O
and	O
,	O
further	O
,	O
suggest	O
a	O
functional	O
redundancy	O
in	O
general	B-protein
coactivators	I-protein
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
July	NULL
1998	NULL
,	NULL
p.	NULL
3803-3810	NULL
0270-7306/98/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Copyright	NULL
©	NULL
1998	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Coactivation	NULL
by	NULL
OCA-B	NULL
:	NULL
Definition	NULL
of	NULL
Critical	NULL
Regions	NULL
and	NULL
Synergism	NULL
with	NULL
General	NULL
Cofactors	NULL
YAN	NULL
LUO	NULL
,	NULL
HUI	NULL
GE	NULL
,	NULL
f	NULL
SEAN	NULL
STEVENS	NULL
,	NULL
HUA	NULL
XIAO	NULL
,	NULL
anp	NULL
ROBERT	NULL
G.	NULL
ROEDER*	NULL
Laboratory	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10021-6399	NULL
Received	NULL
2	NULL
February	NULL
1998/Returned	NULL
for	NULL
modification	NULL
20	NULL
March	NULL
1998/Accepted	NULL
22	NULL
April	NULL
1998	NULL
Molecular	NULL
dissection	NULL
of	NULL
the	NULL
B-cell-specific	NULL
transcription	NULL
coactivator	NULL
OCA-B	NULL
has	NULL
revealed	NULL
distinct	NULL
regions	NULL
important	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
recruitment	NULL
to	NULL
immunoglobulin	NULL
promoters	NULL
through	NULL
interaction	NULL
with	NULL
octamer-bound	NULL
Oct-1	NULL
and	NULL
for	NULL
subsequent	NULL
coactivator	NULL
function	NULL
.	NULL

Further	NULL
analysis	NULL
of	NULL
general	NULL
coactivator	NULL
requirements	NULL
showed	NULL
that	NULL
selective	NULL
removal	NULL
of	NULL
PC4	NULL
from	NULL
the	NULL
essential	NULL
USA	NULL
fraction	NULL
severely	NULL
impairs	NULL
Oct-1	NULL
and	NULL
OCA-B	NULL
function	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
reconstituted	NULL
with	NULL
partially	NULL
purified	NULL
factors	NULL
.	NULL

Full	NULL
activity	NULL
can	NULL
be	NULL
restored	NULL
by	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
recombinant	NULL
PC4	NULL
and	NULL
the	NULL
PC4-depleted	NULL
USA	NULL
fraction	NULL
,	NULL
thus	NULL
suggesting	NULL
a	NULL
joint	NULL
requirement	NULL
for	NULL
PC4	NULL
and	NULL
another	NULL
,	NULL
USA-derived	NULL
component	NULL
(	NULL
s	NULL
)	NULL
for	NULL
optimal	NULL
function	NULL
of	NULL
Oct-1/OCA-B	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
.	NULL

Indeed	NULL
,	NULL
USA-derived	NULL
PC2	NULL
was	NULL
found	NULL
to	NULL
act	NULL
synergistically	NULL
with	NULL
PC4	NULL
in	NULL
reproducing	NULL
the	NULL
function	NULL
of	NULL
intact	NULL
USA	NULL
in	NULL
the	NULL
assay	NULL
system	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
requirement	NULL
for	NULL
PC4	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
,	NULL
OCA-B	NULL
was	NULL
found	NULL
to	NULL
interact	NULL
directly	NULL
with	NULL
PC4	NULL
.	NULL

Surprisingly	NULL
,	NULL
however	NULL
,	NULL
removal	NULL
of	NULL
PC4	NULL
from	NULL
the	NULL
unfractionated	NULL
nuclear	NULL
extract	NULL
has	NULL
no	NULL
detrimental	NULL
effect	NULL
on	NULL
OCA-B/Oct-1-dependent	NULL
transcription	NULL
.	NULL

These	NULL
results	NULL
lead	NULL
to	NULL
a	NULL
general	NULL
model	NULL
for	NULL
the	NULL
synergistic	NULL
function	NULL
of	NULL
activation	NULL
domains	NULL
in	NULL
Oct-1	NULL
and	NULL
OCA-B	NULL
(	NULL
mediated	NULL
by	NULL
the	NULL
combined	NULL
action	NULL
of	NULL
the	NULL
multiple	NULL
USA	NULL
components	NULL
)	NULL
and	NULL
,	NULL
further	NULL
,	NULL
suggest	NULL
a	NULL
functional	NULL
redundancy	NULL
in	NULL
general	NULL
coactivators	NULL
.	NULL

The	NULL
B-cell-specific	NULL
function	NULL
of	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
promoters	NULL
is	NULL
mediated	NULL
by	NULL
an	NULL
octamer	NULL
element	NULL
(	NULL
ATTTGCAT	NULL
)	NULL
and	NULL
was	NULL
thought	NULL
originally	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
an	NULL
octamer-binding	NULL
factor	NULL
(	NULL
Oct-2	NULL
)	NULL
enriched	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
51	NULL
)	NULL
.	NULL

However	NULL
,	NULL
early	NULL
biochemical	NULL
analyses	NULL
indicated	NULL
that	NULL
Ig	NULL
promoters	NULL
could	NULL
function	NULL
equally	NULL
well	NULL
with	NULL
Oct-2	NULL
or	NULL
the	NULL
ubiquitous	NULL
Oct-1	NULL
and	NULL
that	NULL
B-cell-specific	NULL
promoter	NULL
function	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
B-cell-specific	NULL
Oct-l-associated	NULL
coactivator	NULL
designated	NULL
OCA-B	NULL
(	NULL
30	NULL
,	NULL
41	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
established	NULL
a	NULL
new	NULL
paradigm	NULL
for	NULL
cell-specific	NULL
promoter	NULL
activation	NULL
that	NULL
involves	NULL
recruitment	NULL
of	NULL
the	NULL
true	NULL
regulatory	NULL
factor	NULL
to	NULL
the	NULL
cell-specific	NULL
promoter	NULL
element	NULL
through	NULL
interaction	NULL
with	NULL
a	NULL
ubiquitous	NULL
DNA	NULL
binding	NULL
factor	NULL
.	NULL

Subsequent	NULL
genetic	NULL
analyses	NULL
confirmed	NULL
that	NULL
Oct-2	NULL
was	NULL
nonessential	NULL
for	NULL
Ig	NULL
promoter	NULL
activation	NULL
but	NULL
failed	NULL
to	NULL
identify	NULL
the	NULL
responsible	NULL
B-cell-specific	NULL
factor	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

The	NULL
discovery	NULL
of	NULL
OCA-B	NULL
set	NULL
the	NULL
stage	NULL
for	NULL
cloning	NULL
of	NULL
a	NULL
cognate	NULL
cDNA	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
biochemical	NULL
purification	NULL
(	NULL
31	NULL
)	NULL
and	NULL
yeast	NULL
genetic	NULL
screens	NULL
(	NULL
13	NULL
,	NULL
54	NULL
)	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
facilitated	NULL
both	NULL
genetic	NULL
and	NULL
biochemical	NULL
analyses	NULL
of	NULL
OCA-B	NULL
.	NULL

Targeted	NULL
gene	NULL
disruption	NULL
data	NULL
(	NULL
19	NULL
,	NULL
39	NULL
,	NULL
50	NULL
)	NULL
revealed	NULL
that	NULL
OCA-B	NULL
is	NULL
essential	NULL
for	NULL
normal	NULL
patterns	NULL
of	NULL
Ig	NULL
expression	NULL
,	NULL
most	NULL
notably	NULL
antigen-dependent	NULL
responses	NULL
leading	NULL
to	NULL
secondary	NULL
isotype	NULL
production	NULL
,	NULL
but	NULL
not	NULL
for	NULL
antigen-independent	NULL
Ig	NULL
gene	NULL
transcription	NULL
events	NULL
that	NULL
might	NULL
conceivably	NULL
employ	NULL
other	NULL
Oct-1	NULL
coactivators	NULL
.	NULL

Biochemical	NULL
studies	NULL
with	NULL
recombinant	NULL
OCA-B	NULL
have	NULL
confirmed	NULL
the	NULL
originally	NULL
suggested	NULL
mechanisms	NULL
by	NULL
showing	NULL
that	NULL
the	NULL
highly	NULL
related	NULL
POU	NULL
domains	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
15	NULL
,	NULL
16	NULL
,	NULL
and	NULL
45-48	NULL
)	NULL
of	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
,	NULL
but	NULL
not	NULL
that	NULL
of	NULL
Oct-3	NULL
,	NULL
are	NULL
sufficient	NULL
for	NULL
OCA-B	NULL
interaction	NULL
and	NULL
promoter	NULL
recruitment	NULL
(	NULL
13	NULL
,	NULL
31	NULL
,	NULL
54	NULL
)	NULL
.	NULL

More	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
OCA-B	NULL
also	NULL
contacts	NULL
octamer	NULL
nucleotides	NULL
through	NULL
the	NULL
major	NULL
groove	NULL
in	NULL
the	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021-6399	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
212	NULL
)	NULL
327-7600	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
212	NULL
)	NULL
327-7949	NULL
.	NULL

E-mail	NULL
:	NULL
roeder	NULL
@	NULL
rockvax.rockefeller.edu	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Embryology	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Child	NULL
Health	NULL
and	NULL
Human	NULL
Development	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-5431	NULL
.	NULL

3803	NULL
DNA-Oct-1-OCA-B	NULL
complex	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
stronger	NULL
OCA-B	NULL
interaction	NULL
with	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
DNA	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
demonstration	NULL
that	NULL
OCA-B	NULL
can	NULL
discriminate	NULL
among	NULL
octamer	NULL
variants	NULL
for	NULL
formation	NULL
of	NULL
the	NULL
higher-order	NULL
ternary	NULL
complex	NULL
provided	NULL
a	NULL
mechanism	NULL
for	NULL
differential	NULL
activation	NULL
of	NULL
octamer-containing	NULL
promoters	NULL
(	NULL
4	NULL
,	NULL
14	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
inability	NULL
of	NULL
OCA-B	NULL
to	NULL
stimulate	NULL
the	NULL
histone	NULL
2B	NULL
(	NULL
H2B	NULL
)	NULL
promoter	NULL
(	NULL
31	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
functional	NULL
octamer	NULL
element	NULL
identical	NULL
to	NULL
the	NULL
consensus	NULL
Ig	NULL
promoter	NULL
element	NULL
,	NULL
requires	NULL
a	NULL
different	NULL
explanation	NULL
.	NULL

Finally	NULL
,	NULL
while	NULL
corresponding	NULL
POU	NULL
domains	NULL
are	NULL
sufficient	NULL
for	NULL
OCA-B	NULL
recruitment	NULL
to	NULL
Ig	NULL
promoters	NULL
and	NULL
for	NULL
normal	NULL
octamer-mediated	NULL
transcription	NULL
from	NULL
the	NULL
H2B	NULL
promoter	NULL
,	NULL
an	NULL
additional	NULL
Oct-1	NULL
or	NULL
Oct-2	NULL
activation	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
is	NULL
necessary	NULL
for	NULL
functional	NULL
synergy	NULL
with	NULL
OCA-B	NULL
and	NULL
corresponding	NULL
activation	NULL
of	NULL
Ig	NULL
promoters	NULL
(	NULL
31	NULL
)	NULL
.	NULL

When	NULL
assayed	NULL
in	NULL
more	NULL
purified	NULL
reconstituted	NULL
system	NULL
,	NULL
Ig	NULL
promoter	NULL
activation	NULL
by	NULL
OCA-B	NULL
and	NULL
Oct-1	NULL
also	NULL
required	NULL
the	NULL
general	NULL
coactivator	NULL
fraction	NULL
USA	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
general	NULL
initiation	NULL
factors	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
availability	NULL
of	NULL
recombinant	NULL
OCA-B	NULL
and	NULL
in	NULL
vitro	NULL
assay	NULL
systems	NULL
with	NULL
general	NULL
initiation	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
44	NULL
)	NULL
and	NULL
cofactors	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
18	NULL
)	NULL
prompt	NULL
questions	NULL
about	NULL
structure-function	NULL
relationships	NULL
in	NULL
relation	NULL
to	NULL
its	NULL
interaction	NULL
both	NULL
with	NULL
Oct-1	NULL
(	NULL
upstream	NULL
interactions	NULL
)	NULL
and	NULL
,	NULL
poten-tially	NULL
,	NULL
with	NULL
components	NULL
of	NULL
the	NULL
general	NULL
transcription	NULL
machinery	NULL
(	NULL
downstream	NULL
interactions	NULL
)	NULL
.	NULL

As	NULL
predicted	NULL
from	NULL
our	NULL
previous	NULL
model	NULL
invoking	NULL
separate	NULL
domains	NULL
for	NULL
these	NULL
interactions	NULL
(	NULL
31	NULL
)	NULL
,	NULL
mutant	NULL
OCA-B	NULL
defective	NULL
in	NULL
either	NULL
interaction	NULL
would	NULL
,	NULL
in	NULL
prin-ciple	NULL
,	NULL
lead	NULL
to	NULL
defects	NULL
in	NULL
coactivation	NULL
function	NULL
.	NULL

This	NULL
scenario	NULL
is	NULL
reminiscent	NULL
of	NULL
that	NULL
described	NULL
for	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
(	NULL
HSV	NULL
)	NULL
(	NULL
co	NULL
)	NULL
activator	NULL
VP16	NULL
,	NULL
which	NULL
was	NULL
reported	NULL
to	NULL
interact	NULL
with	NULL
promoter-bound	NULL
Oct-1	NULL
through	NULL
the	NULL
POU	NULL
domain	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
26	NULL
,	NULL
43	NULL
)	NULL
;	NULL
have	NULL
a	NULL
conditional	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
25	NULL
,	NULL
52	NULL
,	NULL
but	NULL
see	NULL
reference	NULL
58	NULL
;	NULL
reviewed	NULL
in	NULL
references	NULL
5	NULL
and	NULL
15	NULL
)	NULL
,	NULL
a	NULL
property	NULL
shared	NULL
by	NULL
OCA	NULL
-B	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
;	NULL
and	NULL
provide	NULL
an	NULL
activation	NULL
function	NULL
.	NULL

From	NULL
this	NULL
point	NULL
of	NULL
view	NULL
,	NULL
OCA-B	NULL
may	NULL
represent	NULL
a	NULL
class	NULL
of	NULL
cellular	NULL
counterparts	NULL
of	NULL
viral	NULL
coactivators	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
first	NULL
show	NULL
functional	NULL
analyses	NULL
of	NULL
wild-type	NULL
OCA-B	NULL
versus	NULL
mutant	NULL
derivatives	NULL
to	NULL
define	NULL
domains	NULL
critical	NULL
for	NULL
upstream	NULL
versus	NULL
downstream	NULL
interactions	NULL
.	NULL

We	NULL
then	NULL
present	NULL
a	NULL
3804	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

further	NULL
definition	NULL
of	NULL
general	NULL
cofactor	NULL
requirements	NULL
for	NULL
the	NULL
proper	NULL
function	NULL
of	NULL
Oct-1	NULL
and	NULL
OCA-B	NULL
in	NULL
a	NULL
reconstituted	NULL
system	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
use	NULL
OCA-B	NULL
mutants	NULL
to	NULL
establish	NULL
a	NULL
functional	NULL
linkage	NULL
between	NULL
OCA-B	NULL
and	NULL
general	NULL
cofactors	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
In	NULL
vitro	NULL
transcription	NULL
.	NULL

For	NULL
transcription	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
conditions	NULL
described	NULL
by	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
and	NULL
Luo	NULL
and	NULL
Roeder	NULL
(	NULL
31	NULL
)	NULL
were	NULL
used	NULL
.	NULL

The	NULL
reaction	NULL
mixtures	NULL
(	NULL
25	NULL
pl	NULL
)	NULL
contained	NULL
5	NULL
pl	NULL
of	NULL
transcription	NULL
premix	NULL
(	NULL
200	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
8.4	NULL
]	NULL
;	NULL
15	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
3	NULL
mM	NULL
each	NULL
ATP	NULL
,	NULL
GTP	NULL
,	NULL
CTP	NULL
,	NULL
and	NULL
UTP	NULL
;	NULL
20	NULL
mM	NULL
dithiothre-itol	NULL
,	NULL
40	NULL
U	NULL
of	NULL
RNasin	NULL
)	NULL
;	NULL
5	NULL
pl	NULL
of	NULL
H	NULL
,	NULL
O	NULL
containing	NULL
500	NULL
ng	NULL
of	NULL
the	NULL
BCL	NULL
,	NULL
(	NULL
27	NULL
)	NULL
IgH	NULL
template	NULL
(	NULL
41	NULL
)	NULL
and	NULL
,	NULL
when	NULL
indicated	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
the	NULL
2xSp1	NULL
template	NULL
(	NULL
42	NULL
)	NULL
;	NULL
and	NULL
15	NULL
pl	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
nuclear	NULL
extract	NULL
maintained	NULL
in	NULL
BC100	NULL
(	NULL
30	NULL
;	NULL
typically	NULL
,	NULL
10	NULL
wl	NULL
)	NULL
and	NULL
various	NULL
amounts	NULL
of	NULL
cofactor	NULL
OCA-B	NULL
maintained	NULL
in	NULL
BC100-250-ug/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
with	NULL
compensating	NULL
volumes	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

For	NULL
transcription	NULL
in	NULL
a	NULL
reconstituted	NULL
system	NULL
,	NULL
the	NULL
nuclear	NULL
extract-OCA-B	NULL
mixture	NULL
mentioned	NULL
above	NULL
was	NULL
replaced	NULL
with	NULL
TFII-A	NULL
,	NULL
-B	NULL
,	NULL
-D	NULL
,	NULL
and	NULL
-E/F/H	NULL
plus	NULL
RNA	NULL
polymerase	NULL
II	NULL
and	NULL
other	NULL
factor	NULL
and	NULL
cofactor	NULL
components	NULL
specified	NULL
in	NULL
the	NULL
figures	NULL
and	NULL
legends	NULL
.	NULL

Factors	NULL
in	NULL
this	NULL
system	NULL
were	NULL
stabilized	NULL
by	NULL
1.5-mg/ml	NULL
BSA	NULL
.	NULL

All	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
30°C	NULL
for	NULL
60	NULL
min	NULL
,	NULL
and	NULL
transcripts	NULL
were	NULL
measured	NULL
by	NULL
primer	NULL
extension	NULL
.	NULL

Purification	NULL
of	NULL
factors	NULL
and	NULL
cofactors	NULL
.	NULL

Proteins	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
BC	NULL
buffers	NULL
described	NULL
by	NULL
Luo	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
.	NULL

Numbers	NULL
following	NULL
BC	NULL
indicate	NULL
millimolar	NULL
KCI	NULL
concentrations	NULL
.	NULL

Highly	NULL
purified	NULL
factors	NULL
and	NULL
cofactors	NULL
(	NULL
in	NULL
BC100	NULL
)	NULL
were	NULL
stabilized	NULL
with	NULL
250-pug/ml	NULL
BSA	NULL
.	NULL

Oct-1	NULL
(	NULL
glycosylated	NULL
)	NULL
was	NULL
purified	NULL
from	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
by	NULL
using	NULL
a	NULL
combination	NULL
of	NULL
wheat	NULL
germ	NULL
agglutinin	NULL
and	NULL
octamer	NULL
binding	NULL
site	NULL
affinity	NULL
columns	NULL
as	NULL
described	NULL
by	NULL
Picrani	NULL
et	NULL
al	NULL
.	NULL

(	NULL
41	NULL
)	NULL
.	NULL

General	NULL
transcription	NULL
factors	NULL
and	NULL
cofactors	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Ge	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
and	NULL
Kretzschmar	NULL
et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
.	NULL

Recombinant	NULL
wild-type	NULL
and	NULL
mutant	NULL
OCA-B	NULL
proteins	NULL
were	NULL
expressed	NULL
as	NULL
six-His-tagged	NULL
proteins	NULL
(	NULL
vector	NULL
6His-pET11d	NULL
;	NULL
reference	NULL
17	NULL
)	NULL
in	NULL
Escherichia	NULL
coli	NULL
and	NULL
purified	NULL
.	NULL

Recombinant	NULL
PC4	NULL
was	NULL
expressed	NULL
and	NULL
purified	NULL
as	NULL
described	NULL
by	NULL
Ge	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
.	NULL

Immunodepletion	NULL
of	NULL
PC4	NULL
.	NULL

Immunodepletion	NULL
of	NULL
PC4	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
USA	NULL
fraction	NULL
from	NULL
the	NULL
heparin-Sepharose	NULL
step	NULL
(	NULL
see	NULL
reference	NULL
34	NULL
;	NULL
0.4	NULL
ml	NULL
in	NULL
BC100	NULL
,	NULL
diluted	NULL
to	NULL
2	NULL
ml	NULL
with	NULL
BC600	NULL
)	NULL
was	NULL
passed	NULL
several	NULL
times	NULL
through	NULL
a	NULL
0.4-ml	NULL
protein	NULL
A-agarose	NULL
column	NULL
equilibrated	NULL
in	NULL
BC500	NULL
.	NULL

Half	NULL
of	NULL
the	NULL
flowthrough	NULL
fraction	NULL
served	NULL
as	NULL
a	NULL
source	NULL
of	NULL
mock-depleted	NULL
USA	NULL
.	NULL

The	NULL
other	NULL
half	NULL
was	NULL
passed	NULL
several	NULL
times	NULL
through	NULL
a	NULL
0.2-ml	NULL
anti-PC4	NULL
affinity	NULL
column	NULL
equilibrated	NULL
in	NULL
BC500	NULL
.	NULL

Both	NULL
the	NULL
final	NULL
flowthrough	NULL
fraction	NULL
from	NULL
the	NULL
protein	NULL
A	NULL
column	NULL
and	NULL
that	NULL
from	NULL
the	NULL
anti-PC4	NULL
column	NULL
were	NULL
dialyzed	NULL
to	NULL
BC100	NULL
,	NULL
concentrated	NULL
(	NULL
about	NULL
fivefold	NULL
)	NULL
by	NULL
ultrafiltration	NULL
(	NULL
Amicon	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
and	NULL
used	NULL
as	NULL
mock-depleted	NULL
and	NULL
PC4-depleted	NULL
USA	NULL
fractions	NULL
in	NULL
transcription	NULL
assays	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
depletion	NULL
was	NULL
monitored	NULL
by	NULL
immunoblotting	NULL
various	NULL
fractions	NULL
with	NULL
anti-PC4	NULL
sera	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
PC4	NULL
from	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
a	NULL
similar	NULL
protocol	NULL
,	NULL
except	NULL
for	NULL
the	NULL
omission	NULL
of	NULL
the	NULL
initial	NULL
dilution	NULL
and	NULL
final	NULL
concentration	NULL
steps	NULL
.	NULL

Anti-PC4	NULL
antibodies	NULL
were	NULL
raised	NULL
against	NULL
a	NULL
protein	NULL
containing	NULL
full-length	NULL
PC4	NULL
fused	NULL
to	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
.	NULL

Specific	NULL
anti-PC4	NULL
antibodies	NULL
were	NULL
purified	NULL
from	NULL
crude	NULL
antisera	NULL
by	NULL
using	NULL
an	NULL
immunogen	NULL
affinity	NULL
column	NULL
.	NULL

The	NULL
purified	NULL
antibodies	NULL
were	NULL
then	NULL
cross-linked	NULL
to	NULL
protein	NULL
A-agarose	NULL
,	NULL
yielding	NULL
an	NULL
anti-PC4	NULL
affinity	NULL
column	NULL
.	NULL

Protein-protein	NULL
interaction	NULL
assays	NULL
.	NULL

To	NULL
detect	NULL
a	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
can	NULL
specifically	NULL
bind	NULL
to	NULL
the	NULL
wild-type	NULL
OCA-B	NULL
activation	NULL
domain	NULL
,	NULL
GST	NULL
and	NULL
a	NULL
GST-OCA-B	NULL
fusion	NULL
protein	NULL
(	NULL
containing	NULL
residues	NULL
171	NULL
to	NULL
256	NULL
in	NULL
wild-type	NULL
and	NULL
mutant	NULL
B	NULL
OCA-B	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
expressed	NULL
in	NULL
£	NULL
.	NULL

coli	NULL
and	NULL
then	NULL
purified	NULL
by	NULL
binding	NULL
to	NULL
glutathione-agarose	NULL
beads	NULL
.	NULL

Subsequently	NULL
,	NULL
aliquots	NULL
of	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
in	NULL
BC100	NULL
were	NULL
passed	NULL
through	NULL
the	NULL
resultant	NULL
beads	NULL
equilibrated	NULL
in	NULL
BC100	NULL
.	NULL

After	NULL
extensive	NULL
washing	NULL
of	NULL
the	NULL
resins	NULL
with	NULL
BC100	NULL
,	NULL
the	NULL
bound	NULL
proteins	NULL
were	NULL
eluted	NULL
by	NULL
BC1000	NULL
.	NULL

The	NULL
eluates	NULL
were	NULL
analyzed	NULL
by	NULL
multiple	NULL
immunoblots	NULL
using	NULL
available	NULL
antisera	NULL
against	NULL
various	NULL
general	NULL
factors	NULL
and	NULL
cofactors	NULL
;	NULL
PC4	NULL
was	NULL
the	NULL
sole	NULL
polypeptide	NULL
detected	NULL
by	NULL
immu-noblotting	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
in	NULL
vivo	NULL
function	NULL
of	NULL
OCA-B	NULL
and	NULL
derived	NULL
mutants	NULL
by	NULL
transfec-tion	NULL
.	NULL

cDNAs	NULL
encoding	NULL
wild-type	NULL
and	NULL
mutant	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
A/B	NULL
)	NULL
OCA-B	NULL
proteins	NULL
were	NULL
subcloned	NULL
into	NULL
mammalian	NULL
expression	NULL
vector	NULL
pRC	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

These	NULL
effector	NULL
constructs	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
(	NULL
luciferase	NULL
in	NULL
vector	NULL
pGL3	NULL
;	NULL
Promega	NULL
)	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
BCL	NULL
,	NULL
(	NULL
27	NULL
)	NULL
IgH	NULL
promoter	NULL
.	NULL

The	NULL
transfection	NULL
analyses	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
HeLa	NULL
cells	NULL
by	NULL
using	NULL
conventional	NULL
calcium	NULL
phosphate	NULL
methods	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
48	NULL
h.	NULL
Extracts	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
reporter	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
and	NULL
expression	NULL
was	NULL
assayed	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

In	NULL
cach	NULL
case	NULL
,	NULL
assays	NULL
were	NULL
conducted	NULL
in	NULL
duplicate	NULL
or	NULL
triplicate	NULL
and	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
the	NULL
vector	NULL
CMVBgal	NULL
was	NULL
added	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
levels	NULL
were	NULL
titrated	NULL
carefully	NULL
,	NULL
and	NULL
the	NULL
amounts	NULL
used	NULL
for	NULL
the	NULL
data	NULL
included	NULL
here	NULL
were	NULL
within	NULL
the	NULL
linear	NULL
range	NULL
for	NULL
activation	NULL
.	NULL

Western	NULL
blot	NULL
analyses	NULL
indicated	NULL
that	NULL
the	NULL
OCA-B	NULL
cDNA	NULL
and	NULL
the	NULL
various	NULL
mutant	NULL
forms	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

1mm	NULL
m-	NULL
256	NULL
--	NULL
//	NULL
/	NULL
~	NULL
/	NULL
,	NULL
1	NULL
.	NULL

MLWOKPTA	NULL
:	NULL
238	NULL
%	NULL
*	NULL
++	NULL
*	NULL
243	NULL
(	NULL
domain	NULL
B	NULL
)	NULL
PEQAPAPARP	NULL
18	NULL
(	NULL
domain	NULL
A	NULL
)	NULL
U	NULL
U	NULL
eo	NULL
__e	NULL
eves	NULL
180	NULL
GMFV	NULL
YS	NULL
PVSEPEPEPEPEPEPARP	NULL
203	NULL
E1A	NULL
Mutant	NULL
A	NULL
=	NULL
deletion	NULL
of	NULL
aa	NULL
4-18	NULL
Mutant	NULL
B	NULL
=	NULL
EEEDSD	NULL
-	NULL
#	NULL
RERDSR	NULL
Mutant	NULL
A/B	NULL
=	NULL
combination	NULL
of	NULL
mutation	NULL
in	NULL
A	NULL
plus	NULL
B	NULL
«	NULL
2	NULL
aP	NULL
«	NULL
PC	NULL
ow	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
simple	NULL
linear	NULL
description	NULL
of	NULL
the	NULL
OCA-B	NULL
molecule	NULL
.	NULL

The	NULL
256-residue	NULL
polypeptide	NULL
is	NULL
rich	NULL
in	NULL
proline	NULL
(	NULL
~16	NULL
%	NULL
;	NULL
for	NULL
the	NULL
complete	NULL
sequence	NULL
,	NULL
see	NULL
references	NULL
13	NULL
,	NULL
31	NULL
,	NULL
and	NULL
54	NULL
)	NULL
.	NULL

Relevant	NULL
putative	NULL
functional	NULL
domains	NULL
include	NULL
domain	NULL
A	NULL
(	NULL
with	NULL
its	NULL
sequence	NULL
alignment	NULL
with	NULL
an	NULL
E1A	NULL
segment	NULL
shown	NULL
)	NULL
and	NULL
domain	NULL
B	NULL
(	NULL
with	NULL
acidic	NULL
residues	NULL
marked	NULL
by	NULL
asterisks	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
forms	NULL
of	NULL
OCA-B	NULL
used	NULL
in	NULL
this	NULL
study	NULL
are	NULL
also	NULL
described	NULL
.	NULL

The	NULL
mutant	NULL
proteins	NULL
were	NULL
made	NULL
by	NULL
a	NULL
PCR-based	NULL
strategy	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Protein	NULL
profile	NULL
of	NULL
bacterially	NULL
expressed	NULL
,	NULL
6His-tagged	NULL
wild-type	NULL
OCA-B	NULL
and	NULL
mutant	NULL
forms	NULL
of	NULL
OCA-B	NULL
.	NULL

A	NULL
roughly	NULL
calculated	NULL
0.1	NULL
ng	NULL
each	NULL
of	NULL
the	NULL
proteins	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
polyclonal	NULL
anti-OCA-B	NULL
antibodies	NULL
.	NULL

(	NULL
Given	NULL
that	NULL
all	NULL
three	NULL
mutant	NULL
proteins	NULL
may	NULL
have	NULL
lost	NULL
some	NULL
epitopes	NULL
compared	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
the	NULL
mutant	NULL
proteins	NULL
might	NULL
be	NULL
slightly	NULL
underes-timated	NULL
.	NULL

Nevertheless	NULL
,	NULL
this	NULL
underestimation	NULL
would	NULL
not	NULL
complicate	NULL
our	NULL
analyses	NULL
of	NULL
,	NULL
and	NULL
the	NULL
conclusions	NULL
made	NULL
about	NULL
,	NULL
these	NULL
mutant	NULL
proteins	NULL
.	NULL
)	NULL

The	NULL
amounts	NULL
used	NULL
for	NULL
the	NULL
in	NULL
vitro	NULL
transcription	NULL
analyses	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
were	NULL
based	NULL
on	NULL
this	NULL
estimation	NULL
.	NULL

RESULTS	NULL
Molecular	NULL
dissection	NULL
of	NULL
OCA-B	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
being	NULL
rich	NULL
in	NULL
proline	NULL
(	NULL
~16	NULL
%	NULL
)	NULL
,	NULL
a	NULL
characteristic	NULL
of	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
35	NULL
)	NULL
,	NULL
OCA-B	NULL
displays	NULL
a	NULL
weak	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
viral	NULL
coactivator	NULL
E1A	NULL
(	NULL
31	NULL
;	NULL
domain	NULL
A	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
and	NULL
contains	NULL
a	NULL
putative	NULL
acidic	NULL
activation	NULL
domain	NULL
(	NULL
domain	NULL
B	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
reminiscent	NULL
of	NULL
that	NULL
of	NULL
coactivator	NULL
VP16	NULL
(	NULL
56	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
domains	NULL
are	NULL
important	NULL
for	NULL
OCA-B	NULL
function	NULL
,	NULL
three	NULL
OCA-B	NULL
mutants	NULL
were	NULL
made	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
A	NULL
mutant	NULL
protein	NULL
has	NULL
domain	NULL
A	NULL
(	NULL
amino	NULL
acids	NULL
[	NULL
aa	NULL
]	NULL
4	NULL
to	NULL
18	NULL
)	NULL
deleted	NULL
,	NULL
the	NULL
B	NULL
mutant	NULL
protein	NULL
has	NULL
the	NULL
acidic	NULL
stretch	NULL
neutralized	NULL
,	NULL
and	NULL
the	NULL
A/B	NULL
mutant	NULL
protein	NULL
is	NULL
a	NULL
combinatorial	NULL
double	NULL
mutant	NULL
protein	NULL
.	NULL

For	NULL
in	NULL
vitro	NULL
analyses	NULL
,	NULL
wild-type	NULL
OCA-B	NULL
and	NULL
the	NULL
mutant	NULL
forms	NULL
of	NULL
OCA-B	NULL
were	NULL
expressed	NULL
in	NULL
and	NULL
purified	NULL
from	NULL
bacteria	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
;	NULL
they	NULL
then	NULL
were	NULL
tested	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
stimulate	NULL
an	NULL
Ig	NULL
heavy-chain	NULL
(	NULL
IgH	NULL
,	NULL
BCL	NULL
,	NULL
[	NULL
27	NULL
]	NULL
)	NULL
reporter	NULL
promoter	NULL
in	NULL
a	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

In	NULL
a	NULL
dose-response	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
all	NULL
three	NULL
mutant	NULL
proteins	NULL
showed	NULL
reduced	NULL
transcriptional	NULL
activity	NULL
compared	NULL
to	NULL
wild-type	NULL
OCA-B	NULL
.	NULL

To	NULL
analyze	NULL
in	NULL
vivo	NULL
functions	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
BCL	NULL
,	NULL
IgH	NULL
promoter	NULL
reporter	NULL
and	NULL
cytomegalovirus-driven	NULL
expression	NULL
vectors	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
activities	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
OCA-B	NULL
proteins	NULL
on	NULL
the	NULL
IgH	NULL
promoter	NULL
paralleled	NULL
those	NULL
observed	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Both	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
the	NULL
defect	NULL
in	NULL
the	NULL
combinatorial	NULL
A/B	NULL
mutant	NULL
protein	NULL
was	NULL
more	NULL
severe	NULL
than	NULL
that	NULL
of	NULL
either	NULL
the	NULL
A	NULL
or	NULL
the	NULL
B	NULL
mutant	NULL
protein	NULL
.	NULL

Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
B-CELL-SPECIFIC	NULL
COACTIVATOR	NULL
OCA-B	NULL
_	NULL
3805	NULL
o	NULL
¢®-®	NULL
%	NULL
Nwﬂ	NULL
A	NULL
C	NULL
OCA-B	NULL
+	NULL
.	NULL

<	NULL
4-OctA-POU-1-0CA-B	NULL
igh	NULL
-D-	NULL
<	NULL
»	NULL
-	NULL
»	NULL
an	NULL
an	NULL
«	NULL
n	NULL
an	NULL
#	NULL
B	NULL
-	NULL
»	NULL
m	NULL
ome	NULL
1	NULL
2	NULL
3B	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
p	NULL
Stimulation	NULL
8.0x	NULL
2.7	NULL
%	NULL
2.2x	NULL
14x	NULL
<	NULL
€-OCTA-Fold	NULL
PoU-1	NULL
D	NULL
Nam	NULL
Nuclear	NULL
Extract	NULL
(	NULL
endogenous	NULL
OCA-B	NULL
)	NULL
12	NULL
o	NULL
e	NULL
8+	NULL
\\\°	NULL
``	NULL
§°\§§	NULL
’	NULL
``	NULL
®	NULL
«	NULL
»	NULL
ign	NULL
--	NULL
DBR	NULL
-*	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
n	NULL
a	NULL
o	NULL
a	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Analyses	NULL
of	NULL
wild-type	NULL
(	NULL
Wt	NULL
)	NULL
OCA-B	NULL
and	NULL
mutant	NULL
(	NULL
Mut	NULL
.	NULL
)	NULL

forms	NULL
of	NULL
OCA-B	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
vitro	NULL
transcription	NULL
assay	NULL
.	NULL

As	NULL
indicated	NULL
,	NULL
three	NULL
doses	NULL
of	NULL
wild-type	NULL
OCA-B	NULL
and	NULL
mutant	NULL
OCA-B	NULL
(	NULL
respectively	NULL
,	NULL
10	NULL
ng	NULL
[	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
11	NULL
]	NULL
;	NULL
20	NULL
ng	NULL
[	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
]	NULL
,	NULL
and	NULL
50	NULL
ng	NULL
[	NULL
lanes	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
and	NULL
13	NULL
]	NULL
)	NULL
were	NULL
used	NULL
in	NULL
the	NULL
titration	NULL
experiment	NULL
to	NULL
complement	NULL
a	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
(	NULL
10	NULL
pl	NULL
for	NULL
each	NULL
reaction	NULL
)	NULL
.	NULL

The	NULL
transcripts	NULL
were	NULL
analyzed	NULL
by	NULL
primer	NULL
extension	NULL
as	NULL
described	NULL
by	NULL
Luo	NULL
and	NULL
Roeder	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
(	NULL
-	NULL
)	NULL
was	NULL
a	NULL
control	NULL
(	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
OCA-B	NULL
or	NULL
its	NULL
derivatives	NULL
)	NULL
.	NULL

Transcription	NULL
activation	NULL
levels	NULL
(	NULL
by	NULL
the	NULL
middle	NULL
point	NULL
dosage	NULL
of	NULL
OCA-B	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
20	NULL
ng	NULL
;	NULL
an	NULL
amount	NULL
equivalent	NULL
to	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
OCA-B	NULL
present	NULL
in	NULL
10	NULL
pl	NULL
of	NULL
the	NULL
B-cell	NULL
[	NULL
Nam	NULL
]	NULL
nuclear	NULL
extract	NULL
)	NULL
,	NULL
compared	NULL
to	NULL
lane	NULL
1	NULL
(	NULL
taken	NULL
as	NULL
1	NULL
)	NULL
,	NULL
are	NULL
8	NULL
,	NULL
2.7	NULL
,	NULL
2.2	NULL
,	NULL
and	NULL
1.4	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
the	NULL
B	NULL
,	NULL
A	NULL
,	NULL
and	NULL
A/B	NULL
mutant	NULL
proteins	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
;	NULL
also	NULL
,	NULL
see	NULL
the	NULL
fold	NULL
stimulation	NULL
shown	NULL
under	NULL
each	NULL
corresponding	NULL
lane	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vivo	NULL
(	NULL
transfection	NULL
)	NULL
assay	NULL
.	NULL

An	NULL
IgH	NULL
reporter	NULL
promoter	NULL
construct	NULL
(	NULL
with	NULL
the	NULL
promoter	NULL
inserted	NULL
in	NULL
front	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
effector	NULL
constructs	NULL
(	NULL
expressing	NULL
OCA-B	NULL
or	NULL
its	NULL
mutants	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
)	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Relative	NULL
IgH	NULL
promoter	NULL
activation	NULL
levels	NULL
were	NULL
scored	NULL
by	NULL
measuring	NULL
the	NULL
light	NULL
units	NULL
of	NULL
the	NULL
extracts	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
48	NULL
h	NULL
posttransfection	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
controls	NULL
.	NULL

Taking	NULL
the	NULL
level	NULL
with	NULL
no	NULL
effector	NULL
as	NULL
1	NULL
,	NULL
the	NULL
relative	NULL
levels	NULL
are	NULL
12	NULL
,	NULL
4	NULL
,	NULL
3	NULL
,	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
the	NULL
B	NULL
,	NULL
A	NULL
,	NULL
and	NULL
A/B	NULL
mutant	NULL
proteins	NULL
.	NULL

The	NULL
mutant	NULL
OCA-B	NULL
proteins	NULL
were	NULL
expressed	NULL
at	NULL
levels	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
protein	NULL
in	NULL
transfected	NULL
cells	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-OCA-B	NULL
antibodies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Octamer	NULL
DNA-POU-1	NULL
complex	NULL
supershift	NULL
assay	NULL
.	NULL

POU-1	NULL
is	NULL
a	NULL
truncated	NULL
version	NULL
of	NULL
Oct-1	NULL
containing	NULL
only	NULL
the	NULL
POU	NULL
domain	NULL
,	NULL
sufficient	NULL
to	NULL
bind	NULL
OCA-B	NULL
either	NULL
in	NULL
solution	NULL
or	NULL
when	NULL
on	NULL
DNA	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
reference	NULL
31	NULL
)	NULL
.	NULL

The	NULL
supershift	NULL
condition	NULL
was	NULL
the	NULL
same	NULL
as	NULL
that	NULL
described	NULL
by	NULL
Luo	NULL
and	NULL
Roeder	NULL
(	NULL
31	NULL
)	NULL
,	NULL
except	NULL
that	NULL
approximately	NULL
25-fold	NULL
less	NULL
OCA-B	NULL
(	NULL
or	NULL
its	NULL
mutants	NULL
)	NULL
was	NULL
used	NULL
,	NULL
such	NULL
that	NULL
only	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
binary	NULL
complex	NULL
was	NULL
supershifted	NULL
.	NULL

To	NULL
obtain	NULL
the	NULL
highest	NULL
possible	NULL
resolution	NULL
,	NULL
the	NULL
free	NULL
probe	NULL
(	NULL
a	NULL
labeled	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
IgH	NULL
octamer	NULL
site	NULL
)	NULL
was	NULL
allowed	NULL
to	NULL
run	NULL
out	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
,	NULL
the	NULL
B	NULL
mutant	NULL
protein	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
form	NULL
the	NULL
higher-order	NULL
complex	NULL
,	NULL
which	NULL
was	NULL
even	NULL
denser	NULL
than	NULL
that	NULL
formed	NULL
with	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
for	NULL
a	NULL
reason	NULL
we	NULL
do	NULL
not	NULL
know	NULL
,	NULL
whereas	NULL
the	NULL
A	NULL
mutant	NULL
protein	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
lost	NULL
the	NULL
capacity	NULL
to	NULL
bind	NULL
the	NULL
binary	NULL
complex	NULL
.	NULL

Given	NULL
that	NULL
the	NULL
combinatorial	NULL
A/B	NULL
mutant	NULL
protein	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
could	NULL
give	NULL
rise	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
residual	NULL
level	NULL
of	NULL
the	NULL
ternary	NULL
complex	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
introduction	NULL
of	NULL
the	NULL
B	NULL
mutant	NULL
protein	NULL
created	NULL
a	NULL
conformational	NULL
change	NULL
that	NULL
can	NULL
increase	NULL
the	NULL
POU-OCA-B	NULL
interaction	NULL
even	NULL
with	NULL
domain	NULL
A	NULL
deleted	NULL
.	NULL

We	NULL
emphasize	NULL
that	NULL
such	NULL
a	NULL
complication	NULL
in	NULL
the	NULL
binding	NULL
assay	NULL
did	NULL
not	NULL
complicate	NULL
our	NULL
in	NULL
vitro	NULL
transcription	NULL
analyses	NULL
and	NULL
conclusions	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Test	NULL
of	NULL
dominant	NULL
negative	NULL
potentials	NULL
of	NULL
wild-type	NULL
OCA-B	NULL
and	NULL
its	NULL
mutant	NULL
forms	NULL
.	NULL

Eight	NULL
microliters	NULL
of	NULL
B-cell	NULL
(	NULL
Nam	NULL
)	NULL
nuclear	NULL
extract	NULL
was	NULL
used	NULL
for	NULL
each	NULL
reaction	NULL
(	NULL
there	NULL
is	NULL
~2	NULL
ng	NULL
of	NULL
endogenous	NULL
OCA-B	NULL
per	NULL
pl	NULL
in	NULL
this	NULL
nuclear	NULL
extract	NULL
[	NULL
see	NULL
above	NULL
]	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extract	NULL
was	NULL
supplemented	NULL
with	NULL
either	NULL
BC100	NULL
buffer	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
,	NULL
as	NULL
indicated	NULL
,	NULL
recombinant	NULL
wild-type	NULL
or	NULL
mutant	NULL
OCA-B	NULL
(	NULL
~100	NULL
ng	NULL
,	NULL
for	NULL
a	NULL
molar	NULL
ratio	NULL
of	NULL
~6:1	NULL
over	NULL
the	NULL
endogenous	NULL
OCA-B	NULL
)	NULL
in	NULL
BC100	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
.	NULL

The	NULL
transcripts	NULL
were	NULL
analyzed	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
A.	NULL
Quantitation	NULL
of	NULL
the	NULL
activation	NULL
levels	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

These	NULL
mutant	NULL
B	NULL
results	NULL
suggest	NULL
that	NULL
domain	NULL
B	NULL
is	NULL
a	NULL
major	NULL
activation	NULL
domain	NULL
of	NULL
the	NULL
OCA-B	NULL
molecule	NULL
.	NULL

Further	NULL
confirming	NULL
this	NULL
notion	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
while	NULL
a	NULL
Gal4	NULL
(	NULL
1-94	NULL
)	NULL
-OCA-B	NULL
fusion	NULL
protein	NULL
functions	NULL
as	NULL
an	NULL
activator	NULL
on	NULL
promoters	NULL
containing	NULL
Gal4	NULL
binding	NULL
sites	NULL
,	NULL
a	NULL
mutant	NULL
protein	NULL
with	NULL
a	NULL
deletion	NULL
encompassing	NULL
domain	NULL
B	NULL
loses	NULL
the	NULL
activation	NULL
capability	NULL
(	NULL
53	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
mutant	NULL
B	NULL
results	NULL
differ	NULL
somewhat	NULL
from	NULL
those	NULL
reported	NULL
by	NULL
Gstaiger	NULL
et	NULL
al	NULL
.	NULL

(	NULL
14	NULL
)	NULL
,	NULL
who	NULL
found	NULL
that	NULL
large	NULL
C-terminal	NULL
deletions	NULL
(	NULL
aa	NULL
193	NULL
to	NULL
256	NULL
and	NULL
123	NULL
to	NULL
256	NULL
)	NULL
had	NULL
no	NULL
detrimental	NULL
effects	NULL
on	NULL
the	NULL
coactivation	NULL
function	NULL
of	NULL
OCA-B	NULL
in	NULL
transfection	NULL
assays	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
our	NULL
transfection	NULL
assays	NULL
,	NULL
even	NULL
a	NULL
smaller	NULL
C-terminal	NULL
deletion	NULL
in	NULL
OCA-B	NULL
(	NULL
aa	NULL
209	NULL
to	NULL
256	NULL
;	NULL
a	NULL
deletion	NULL
encompassing	NULL
domain	NULL
B	NULL
)	NULL
was	NULL
found	NULL
to	NULL
impair	NULL
the	NULL
coactivation	NULL
function	NULL
of	NULL
OCA-B	NULL
(	NULL
53	NULL
)	NULL
.	NULL

One	NULL
explanation	NULL
for	NULL
this	NULL
apparent	NULL
discrepancy	NULL
is	NULL
that	NULL
the	NULL
more	NULL
extensive	NULL
C-terminal	NULL
deletion	NULL
mutant	NULL
proteins	NULL
of	NULL
Gstaiger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
which	NULL
still	NULL
had	NULL
activation	NULL
function	NULL
in	NULL
their	NULL
assay	NULL
,	NULL
may	NULL
have	NULL
also	NULL
lost	NULL
an	NULL
intrinsic	NULL
inhibitory	NULL
domain	NULL
that	NULL
normally	NULL
masks	NULL
an	NULL
otherwise	NULL
silent	NULL
activation	NULL
function	NULL
(	NULL
residing	NULL
between	NULL
residues	NULL
66	NULL
and	NULL
122	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
in	NULL
the	NULL
transfection	NULL
assays	NULL
of	NULL
Gstaiger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
the	NULL
effectors	NULL
were	NULL
overexpressed	NULL
,	NULL
amplifying	NULL
minor	NULL
activation	NULL
domains	NULL
whose	NULL
effects	NULL
normally	NULL
would	NULL
not	NULL
be	NULL
observed	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
second	NULL
possibility	NULL
,	NULL
similar	NULL
mutant	NULL
proteins	NULL
,	NULL
when	NULL
carefully	NULL
titrated	NULL
,	NULL
were	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
defective	NULL
in	NULL
our	NULL
studies	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Artificial	NULL
coactivation	NULL
by	NULL
OCA-B	NULL
or	NULL
its	NULL
derivatives	NULL
(	NULL
when	NULL
in	NULL
excess	NULL
)	NULL
may	NULL
also	NULL
result	NULL
from	NULL
their	NULL
less	NULL
functionally	NULL
relevant	NULL
interactions	NULL
with	NULL
DNA	NULL
or	NULL
with	NULL
the	NULL
basal	NULL
machinery	NULL
.	NULL

Thus	NULL
,	NULL
high	NULL
doses	NULL
of	NULL
the	NULL
A	NULL
and	NULL
B	NULL
mutant	NULL
proteins	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
the	NULL
A/B	NULL
mutant	NULL
protein	NULL
cause	NULL
detectable	NULL
stimulation	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
53	NULL
)	NULL
.	NULL

This	NULL
is	NULL
exemplified	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
which	NULL
shows	NULL
that	NULL
the	NULL
largest	NULL
amounts	NULL
of	NULL
mutant	NULL
OCA-B	NULL
had	NULL
measurable	NULL
effects	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
mutant	NULL
OCA-B	NULL
proteins	NULL
were	NULL
next	NULL
checked	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
supershift	NULL
a	NULL
complex	NULL
containing	NULL
an	NULL
octamer	NULL
element	NULL
and	NULL
the	NULL
DNA	NULL
binding	NULL
(	NULL
POU	NULL
)	NULL
domain	NULL
of	NULL
Oct-1	NULL
in	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
domain	NULL
A	NULL
provides	NULL
a	NULL
determinant	NULL
for	NULL
POU	NULL
domain	NULL
interaction	NULL
,	NULL
its	NULL
deletion	NULL
essentially	NULL
abrogated	NULL
the	NULL
ability	NULL
of	NULL
OCA-B	NULL
to	NULL
form	NULL
the	NULL
ternary	NULL
complex	NULL
(	NULL
compare	NULL
lane	NULL
4	NULL
,	NULL
Mut	NULL
.	NULL

A	NULL
,	NULL
to	NULL
lane	NULL
2	NULL
,	NULL
Wt	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
suggests	NULL
that	NULL
the	NULL
coactivation	NULL
defect	NULL
of	NULL
mutant	NULL
A	NULL
is	NULL
due	NULL
largely	NULL
to	NULL
its	NULL
lack	NULL
of	NULL
an	NULL
upstream	NULL
interaction	NULL
with	NULL
Oct-1	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
B	NULL
region	NULL
3806	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

mutation	NULL
actually	NULL
enhanced	NULL
the	NULL
ability	NULL
of	NULL
OCA-B	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
DNA-POU-1	NULL
complex	NULL
(	NULL
compare	NULL
lane	NULL
3	NULL
,	NULL
Mut	NULL
.	NULL

B	NULL
,	NULL
to	NULL
lane	NULL
2	NULL
,	NULL
Wt	NULL
)	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
the	NULL
enhancement	NULL
is	NULL
not	NULL
known	NULL
.	NULL

(	NULL
However	NULL
,	NULL
given	NULL
that	NULL
the	NULL
combined	NULL
A/B	NULL
mutant	NULL
protein	NULL
[	NULL
lane	NULL
5	NULL
]	NULL
showed	NULL
a	NULL
residual	NULL
level	NULL
of	NULL
ternary	NULL
complex	NULL
formation	NULL
,	NULL
one	NULL
likely	NULL
scenario	NULL
[	NULL
also	NULL
offered	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

2C	NULL
]	NULL
is	NULL
that	NULL
the	NULL
domain	NULL
B	NULL
mutation	NULL
results	NULL
in	NULL
a	NULL
conformational	NULL
change	NULL
that	NULL
can	NULL
increase	NULL
the	NULL
POU-OCA-B	NULL
interaction	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
domain	NULL
A	NULL
.	NULL

Such	NULL
a	NULL
conformational	NULL
change	NULL
may	NULL
also	NULL
contribute	NULL
,	NULL
along	NULL
with	NULL
the	NULL
loss	NULL
of	NULL
acidic	NULL
residues	NULL
per	NULL
se	NULL
,	NULL
to	NULL
the	NULL
coactivation	NULL
defect	NULL
of	NULL
the	NULL
B	NULL
mutant	NULL
protein	NULL
.	NULL
)	NULL

Nevertheless	NULL
,	NULL
given	NULL
that	NULL
the	NULL
B	NULL
mutant	NULL
protein	NULL
maintains	NULL
the	NULL
ability	NULL
to	NULL
supershift	NULL
an	NULL
octamer-POU-1	NULL
complex	NULL
,	NULL
its	NULL
coactivation	NULL
defect	NULL
most	NULL
likely	NULL
originates	NULL
from	NULL
lack	NULL
of	NULL
a	NULL
downstream	NULL
interaction	NULL
(	NULL
s	NULL
)	NULL
.	NULL

By	NULL
virtue	NULL
of	NULL
a	NULL
lack	NULL
of	NULL
both	NULL
interactions	NULL
,	NULL
it	NULL
is	NULL
reasonable	NULL
that	NULL
the	NULL
A/B	NULL
double	NULL
mutant	NULL
protein	NULL
shows	NULL
an	NULL
even	NULL
more	NULL
reduced	NULL
coactivation	NULL
capacity	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

To	NULL
further	NULL
establish	NULL
these	NULL
ideas	NULL
,	NULL
dominant	NULL
negative	NULL
potentials	NULL
of	NULL
wild-type	NULL
versus	NULL
mutant	NULL
OCA-B	NULL
proteins	NULL
were	NULL
tested	NULL
.	NULL

Namalwa	NULL
cell	NULL
(	NULL
Nam	NULL
;	NULL
a	NULL
B-cell	NULL
lymphoma	NULL
line	NULL
)	NULL
nuclear	NULL
extract	NULL
was	NULL
supplemented	NULL
with	NULL
recombinant	NULL
proteins	NULL
at	NULL
a	NULL
6:1	NULL
molar	NULL
ratio	NULL
of	NULL
exogenous	NULL
to	NULL
endogenous	NULL
OCA-B	NULL
,	NULL
and	NULL
the	NULL
IgH	NULL
promoter	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

As	NULL
predicted	NULL
,	NULL
the	NULL
B	NULL
mutant	NULL
protein	NULL
showed	NULL
a	NULL
significant	NULL
dominant	NULL
negative	NULL
effect	NULL
(	NULL
compare	NULL
lane	NULL
3	NULL
to	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
it	NULL
can	NULL
bind	NULL
strongly	NULL
to	NULL
the	NULL
IgH	NULL
promoter-Oct-1	NULL
complex	NULL
and	NULL
interfere	NULL
,	NULL
competitively	NULL
,	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
endogenous	NULL
OCA-B	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
A	NULL
and	NULL
A/B	NULL
mutant	NULL
proteins	NULL
had	NULL
no	NULL
(	NULL
or	NULL
marginal	NULL
)	NULL
effects	NULL
(	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
to	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
whereas	NULL
exogenously	NULL
added	NULL
wild-type	NULL
OCA-B	NULL
slightly	NULL
boosted	NULL
IgH	NULL
promoter	NULL
activity	NULL
(	NULL
compare	NULL
lane	NULL
2	NULL
to	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
the	NULL
A	NULL
mutant	NULL
protein	NULL
,	NULL
which	NULL
maintains	NULL
the	NULL
normal	NULL
domain	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
to	NULL
exert	NULL
a	NULL
dominant	NULL
negative	NULL
effect	NULL
suggests	NULL
that	NULL
OCA-B	NULL
may	NULL
interact	NULL
with	NULL
a	NULL
downstream	NULL
target	NULL
(	NULL
s	NULL
)	NULL
more	NULL
strongly	NULL
when	NULL
it	NULL
is	NULL
on	NULL
the	NULL
promoter	NULL
than	NULL
when	NULL
it	NULL
is	NULL
free	NULL
in	NULL
solution	NULL
.	NULL

Mechanism	NULL
of	NULL
action	NULL
of	NULL
OCA-B	NULL
:	NULL
essential	NULL
role	NULL
for	NULL
PC4	NULL
and	NULL
synergism	NULL
with	NULL
PC2	NULL
in	NULL
a	NULL
purified	NULL
reconstituted	NULL
system	NULL
.	NULL

Because	NULL
OCA-B	NULL
alone	NULL
can	NULL
confer	NULL
B-cell	NULL
level	NULL
activation	NULL
on	NULL
Ig	NULL
promoters	NULL
,	NULL
its	NULL
function	NULL
has	NULL
been	NULL
analyzed	NULL
mainly	NULL
in	NULL
crude	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
(	NULL
see	NULL
above	NULL
and	NULL
references	NULL
30	NULL
and	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
an	NULL
earlier	NULL
study	NULL
(	NULL
31	NULL
)	NULL
indicated	NULL
that	NULL
it	NULL
can	NULL
also	NULL
function	NULL
in	NULL
a	NULL
system	NULL
reconstituted	NULL
with	NULL
Oct-1	NULL
,	NULL
highly	NULL
purified	NULL
HeLa-derived	NULL
basal	NULL
factors	NULL
and	NULL
RNA	NULL
polymerase	NULL
II	NULL
,	NULL
and	NULL
general	NULL
coactivator	NULL
fraction	NULL
USA	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
Ig	NULL
promoter	NULL
activation	NULL
by	NULL
the	NULL
specialized	NULL
coactivator	NULL
OCA-B	NULL
requires	NULL
still	NULL
other	NULL
general	NULL
(	NULL
USA-derived	NULL
)	NULL
cofactors	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
18	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
transcription	NULL
activation	NULL
by	NULL
Gal4-based	NULL
activators	NULL
on	NULL
model	NULL
promoters	NULL
with	NULL
multiple	NULL
Gald4	NULL
sites	NULL
,	NULL
the	NULL
USA-derived	NULL
positive	NULL
cofactor	NULL
PC4	NULL
can	NULL
replace	NULL
,	NULL
and	NULL
is	NULL
as	NULL
potent	NULL
as	NULL
,	NULL
the	NULL
complete	NULL
USA	NULL
fraction	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
11	NULL
,	NULL
22	NULL
;	NULL
reviewed	NULL
in	NULL
reference	NULL
18	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
earlier	NULL
study	NULL
showed	NULL
that	NULL
PC4	NULL
alone	NULL
could	NULL
not	NULL
substitute	NULL
for	NULL
USA	NULL
in	NULL
mediating	NULL
Oct-1/0CA-B	NULL
function	NULL
in	NULL
a	NULL
reconstituted	NULL
system	NULL
(	NULL
31	NULL
)	NULL
,	NULL
thus	NULL
raising	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
the	NULL
Gal4-based	NULL
artificial	NULL
system	NULL
had	NULL
``	NULL
short-circuited	NULL
``	NULL
a	NULL
regulatory	NULL
pathway	NULL
normally	NULL
requiring	NULL
more	NULL
than	NULL
one	NULL
component	NULL
of	NULL
the	NULL
USA	NULL
fraction	NULL
.	NULL

To	NULL
gain	NULL
further	NULL
insights	NULL
into	NULL
this	NULL
question	NULL
,	NULL
the	NULL
first	NULL
objective	NULL
was	NULL
to	NULL
determine	NULL
whether	NULL
PC4	NULL
is	NULL
,	NULL
indeed	NULL
,	NULL
essential	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
USA	NULL
to	NULL
mediate	NULL
activation	NULL
by	NULL
Oct-1	NULL
and	NULL
OCA-B	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
PC4	NULL
was	NULL
immunodepleted	NULL
from	NULL
the	NULL
USA	NULL
fraction	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
PC4-deficient	NULL
USA	NULL
to	NULL
support	NULL
OCA-B	NULL
function	NULL
with	NULL
Oct-1	NULL
was	NULL
assessed	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

The	NULL
PC4-free	NULL
USA	NULL
was	NULL
found	NULL
to	NULL
be	NULL
almost	NULL
completely	NULL
inactive	NULL
in	NULL
this	NULL
system	NULL
(	NULL
compare	NULL
lane	NULL
7	NULL
to	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
PC4	NULL
is	NULL
,	NULL
indeed	NULL
,	NULL
an	NULL
essential	NULL
USA	NULL
component	NULL
for	NULL
Oct-1	NULL
and	NULL
OCA-B	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

P	NULL
A	NULL
6299109	NULL
»	NULL
o	NULL
h	NULL
eQ-	NULL
“	NULL
e	NULL
***	NULL
se	NULL
Foe	NULL
.	NULL

ye	NULL
?	NULL

go	NULL
``	NULL
``	NULL
40	NULL
``	NULL
¢	NULL
``	NULL
yo	NULL
H-	NULL
K	NULL
'	NULL
aam	NULL
B	NULL
TFIl-A	NULL
,	NULL
-B	NULL
,	NULL
-D	NULL
,	NULL
-E/F/H	NULL
,	NULL
Pol	NULL
II	NULL
[	NULL
OG	NULL
aes	NULL
S6	NULL
``	NULL
ger	NULL
w	NULL
USA	NULL
40°	NULL
``	NULL
[	NULL
O-	NULL
07°90	NULL
rPC4	NULL
+	NULL
Oct-1	NULL
+	NULL
+o+	NULL
+o	NULL
+o+	NULL
OCA-B	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
igh	NULL
-	NULL
»	NULL
C	NULL
TFII-A	NULL
,	NULL
-B	NULL
,	NULL
-D	NULL
,	NULL
-E/F/H	NULL
,	NULL
Pol	NULL
II	NULL
Oct-1	NULL
,	NULL
OCA-B	NULL
USA	NULL
+	NULL
rPC4	NULL
++	NULL
PC2	NULL
++	NULL
+	NULL
+++	NULL
-	NULL
~-88	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
+o	NULL
++	NULL
+	NULL
igh	NULL
-	NULL
»	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

PC4	NULL
as	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
USA	NULL
and	NULL
acting	NULL
synergistically	NULL
with	NULL
PC2	NULL
,	NULL
to	NULL
support	NULL
the	NULL
function	NULL
of	NULL
OCA-B	NULL
in	NULL
a	NULL
reconstituted	NULL
transcription	NULL
system	NULL
.	NULL

(	NULL
A	NULL
)	NULL
PC4	NULL
depletion	NULL
(	NULL
dep	NULL
.	NULL
)	NULL

from	NULL
the	NULL
USA	NULL
coactivator	NULL
fraction	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
from	NULL
the	NULL
nuclear	NULL
extract	NULL
(	NULL
NE	NULL
;	NULL
right	NULL
panel	NULL
;	NULL
the	NULL
treated	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
in	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
completion	NULL
of	NULL
the	NULL
depletion	NULL
was	NULL
examined	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-PC4	NULL
antibodies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IgH	NULL
promoter	NULL
activity	NULL
was	NULL
analyzed	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
with	NULL
components	NULL
of	NULL
general	NULL
factors	NULL
and	NULL
RNA	NULL
polymerase	NULL
II	NULL
(	NULL
top	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
of	NULL
Oct-1	NULL
,	NULL
OCA-B	NULL
,	NULL
or	NULL
the	NULL
USA	NULL
fraction	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Lanes	NULL
1	NULL
to	NULL
5	NULL
demonstrate	NULL
an	NULL
IgH	NULL
promoter	NULL
dependency	NULL
on	NULL
activator	NULL
Oct-1	NULL
,	NULL
general	NULL
coactivator	NULL
fraction	NULL
USA	NULL
,	NULL
and	NULL
specialized	NULL
coactivator	NULL
OCA-B	NULL
.	NULL

Oct-1	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
to	NULL
lane	NULL
4	NULL
,	NULL
which	NULL
represents	NULL
a	NULL
complete	NULL
set	NULL
of	NULL
components	NULL
sufficient	NULL
to	NULL
bring	NULL
about	NULL
a	NULL
high	NULL
level	NULL
of	NULL
IgH	NULL
promoter	NULL
transcription	NULL
)	NULL
.	NULL

In	NULL
an	NULL
otherwise	NULL
complete	NULL
system	NULL
,	NULL
the	NULL
transcription	NULL
is	NULL
stimulated	NULL
~15-fold	NULL
by	NULL
USA	NULL
and	NULL
~8-fold	NULL
by	NULL
OCA-B	NULL
(	NULL
compare	NULL
lane	NULL
1	NULL
,	NULL
missing	NULL
USA	NULL
,	NULL
and	NULL
lane	NULL
5	NULL
,	NULL
missing	NULL
OCA-B	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
lane	NULL
4	NULL
,	NULL
complete	NULL
)	NULL
.	NULL

Lanes	NULL
6	NULL
to	NULL
8	NULL
demonstrate	NULL
that	NULL
PC4	NULL
is	NULL
an	NULL
essential	NULL
component	NULL
of	NULL
USA	NULL
to	NULL
support	NULL
the	NULL
function	NULL
of	NULL
OCA-B	NULL
in	NULL
the	NULL
reconstituted	NULL
transcription	NULL
system	NULL
.	NULL

The	NULL
defect	NULL
of	NULL
the	NULL
PC4-depleted	NULL
USA	NULL
fraction	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
compared	NULL
to	NULL
the	NULL
complete	NULL
USA	NULL
fraction	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
can	NULL
be	NULL
rescued	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
50	NULL
ng	NULL
of	NULL
recombinant	NULL
PC4	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
PC4-PC2	NULL
synergism	NULL
for	NULL
the	NULL
function	NULL
of	NULL
OCA-B	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
.	NULL

Components	NULL
(	NULL
top	NULL
)	NULL
were	NULL
used	NULL
to	NULL
transcribe	NULL
the	NULL
IgH	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
or	NULL
++	NULL
)	NULL
of	NULL
a	NULL
general	NULL
coactivator	NULL
(	NULL
s	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
coactivation	NULL
are	NULL
(	NULL
compared	NULL
to	NULL
lane	NULL
1	NULL
)	NULL
~15-fold	NULL
by	NULL
USA	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
~1.5-	NULL
to	NULL
3-fold	NULL
by	NULL
PC2	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
3	NULL
)	NULL
,	NULL
~3-	NULL
to	NULL
5-fold	NULL
by	NULL
PC4	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
4	NULL
)	NULL
,	NULL
and	NULL
~10-	NULL
to	NULL
15-fold	NULL
by	NULL
PC2	NULL
plus	NULL
PC4	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Amounts	NULL
of	NULL
factors	NULL
used	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
(	NULL
for	NULL
both	NULL
B	NULL
and	NULL
C	NULL
)	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
TFII-A	NULL
,	NULL
0.5	NULL
wl	NULL
;	NULL
recombinant	NULL
TFH-B	NULL
,	NULL
50	NULL
ng	NULL
;	NULL
TFI-D	NULL
,	NULL
2	NULL
wl	NULL
;	NULL
TFII-E/F/H	NULL
fraction	NULL
,	NULL
3.5	NULL
pl	NULL
;	NULL
RNA	NULL
polymerase	NULL
II	NULL
,	NULL
0.25	NULL
wl	NULL
;	NULL
Oct-1	NULL
(	NULL
when	NULL
added	NULL
)	NULL
,	NULL
20	NULL
ng	NULL
;	NULL
recombinant	NULL
OCA-B	NULL
,	NULL
50	NULL
ng	NULL
;	NULL
recombinant	NULL
PC4	NULL
,	NULL
25	NULL
(	NULL
+	NULL
)	NULL
and	NULL
50	NULL
(	NULL
++	NULL
)	NULL
ng	NULL
;	NULL
USA	NULL
,	NULL
mock-depleted	NULL
USA	NULL
and	NULL
PC4-depleted	NULL
USA	NULL
,	NULL
1	NULL
pl	NULL
of	NULL
each	NULL
;	NULL
PC2	NULL
,	NULL
1	NULL
(	NULL
+	NULL
)	NULL
and	NULL
2	NULL
(	NULL
++	NULL
)	NULL
pl	NULL
.	NULL

function	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
.	NULL

The	NULL
transcription	NULL
level	NULL
was	NULL
almost	NULL
fully	NULL
restored	NULL
by	NULL
addition	NULL
of	NULL
recombinant	NULL
PC4	NULL
protein	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Given	NULL
that	NULL
PC4	NULL
alone	NULL
could	NULL
not	NULL
replace	NULL
the	NULL
USA	NULL
fraction	NULL
to	NULL
support	NULL
Oct-1	NULL
and	NULL
OCA-B	NULL
function	NULL
(	NULL
31	NULL
)	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
it	NULL
must	NULL
act	NULL
synergistically	NULL
with	NULL
another	NULL
component	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
USA	NULL
fraction	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
component	NULL
(	NULL
s	NULL
)	NULL
that	NULL
acts	NULL
in	NULL
conjunction	NULL
with	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
PCA	NULL
,	NULL
native	NULL
and	NULL
PC4-depleted	NULL
USA	NULL
fractions	NULL
were	NULL
further	NULL
fractionated	NULL
.	NULL

An	NULL
activity	NULL
chromatographically	NULL
identical	NULL
to	NULL
PC2	NULL
(	NULL
24	NULL
)	NULL
was	NULL
found	NULL
to	NULL
be	NULL
jointly	NULL
required	NULL
with	NULL
the	NULL
recombinant	NULL
PC4	NULL
to	NULL
fully	NULL
support	NULL
the	NULL
Oct-1-	NULL
and	NULL
OCA-B-dependent	NULL
activation	NULL
of	NULL
the	NULL
IgH	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
fraction	NULL
containing	NULL
PC1	NULL
and	NULL
PC3	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
PC4	NULL
,	NULL
was	NULL
inactive	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
,	NULL
appropriate	NULL
titration	NULL
of	NULL
both	NULL
PC4	NULL
and	NULL
PC2	NULL
produced	NULL
a	NULL
transcription	NULL
level	NULL
equivalent	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
the	NULL
intact	NULL
USA	NULL
fraction	NULL
(	NULL
compare	NULL
lane	NULL
7	NULL
to	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
and	NULL
in	NULL
agreement	NULL
with	NULL
prior	NULL
studies	NULL
of	NULL
PC4	NULL
(	NULL
31	NULL
)	NULL
,	NULL
the	NULL
IgH	NULL
promoter	NULL
activity	NULL
was	NULL
compromised	NULL
in	NULL
the	NULL
transcription	NULL
system	NULL
containing	NULL
either	NULL
PC4	NULL
or	NULL
PC2	NULL
alone	NULL
(	NULL
compare	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
to	NULL
lanes	NULL
2	NULL
,	NULL
7	NULL
,	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Increasing	NULL
the	NULL
level	NULL
of	NULL
PC2	NULL
did	NULL
not	NULL
boost	NULL
the	NULL
transcription	NULL
and	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
of	NULL
earlier	NULL
studies	NULL
(	NULL
11	NULL
,	NULL
22	NULL
)	NULL
,	NULL
increasing	NULL
the	NULL
level	NULL
of	NULL
PC4	NULL
eventually	NULL
repressed	NULL
the	NULL
transcription	NULL
system	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
document	NULL
a	NULL
synergism	NULL
between	NULL
PC4	NULL
and	NULL
PC2	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
optimal	NULL
Oct-1	NULL
and	NULL
OCA-B	NULL
function	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
present	NULL
analysis	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
that	NULL
in	NULL
our	NULL
previous	NULL
study	NULL
describing	NULL
the	NULL
cloning	NULL
of	NULL
OCA-B	NULL
(	NULL
31	NULL
)	NULL
,	NULL
used	NULL
increased	NULL
amounts	NULL
of	NULL
promoter	NULL
template	NULL
DNA	NULL
,	NULL
as	NULL
well	NULL
as	NULL
larger	NULL
amounts	NULL
of	NULL
various	NULL
transcription	NULL
factors	NULL
,	NULL
to	NULL
maximize	NULL
the	NULL
promoter	NULL
activity	NULL
such	NULL
that	NULL
,	NULL
while	NULL
maintaining	NULL
8-	NULL
to	NULL
10-fold	NULL
coactivation	NULL
by	NULL
OCA-B	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IgH	NULL
transcription	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
is	NULL
more	NULL
comparable	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
a	NULL
crude	NULL
system	NULL
.	NULL

The	NULL
considerable	NULL
activation	NULL
by	NULL
PC4	NULL
alone	NULL
observed	NULL
here	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
to	NULL
lane	NULL
1	NULL
)	NULL
contrasts	NULL
with	NULL
the	NULL
previous	NULL
report	NULL
showing	NULL
almost	NULL
no	NULL
activation	NULL
by	NULL
PC4	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
in	NULL
reference	NULL
31	NULL
)	NULL
but	NULL
may	NULL
reflect	NULL
either	NULL
genuine	NULL
coactivation	NULL
by	NULL
PC4	NULL
intrinsic	NULL
to	NULL
this	NULL
particular	NULL
redefined	NULL
system	NULL
or	NULL
,	NULL
given	NULL
the	NULL
observed	NULL
PCZ-PCA	NULL
synergism	NULL
,	NULL
minor	NULL
PC2	NULL
contamination	NULL
in	NULL
the	NULL
partially	NULL
purified	NULL
TFIID	NULL
and	NULL
the	NULL
TFIIE/F/H	NULL
fractions	NULL
that	NULL
were	NULL
added	NULL
at	NULL
higher	NULL
levels	NULL
to	NULL
accommodate	NULL
a	NULL
higher	NULL
template	NULL
dose	NULL
.	NULL

Because	NULL
PC2	NULL
is	NULL
still	NULL
poorly	NULL
defined	NULL
,	NULL
we	NULL
can	NULL
not	NULL
distinguish	NULL
these	NULL
two	NULL
possibilities	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
PC4-PC2	NULL
synergism	NULL
was	NULL
clearly	NULL
evident	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

Identification	NULL
of	NULL
PC4	NULL
as	NULL
a	NULL
downstream	NULL
target	NULL
for	NULL
OCA-B	NULL
function	NULL
.	NULL

As	NULL
mentioned	NULL
earlier	NULL
,	NULL
the	NULL
defect	NULL
of	NULL
the	NULL
B	NULL
mutant	NULL
form	NULL
of	NULL
OCA-B	NULL
is	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
a	NULL
downstream	NULL
interaction	NULL
.	NULL

This	NULL
prompted	NULL
us	NULL
to	NULL
search	NULL
for	NULL
an	NULL
OCA-B	NULL
downstream	NULL
tar-get	NULL
(	NULL
s	NULL
)	NULL
.	NULL

PC4	NULL
seemed	NULL
a	NULL
likely	NULL
target	NULL
in	NULL
view	NULL
of	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
function	NULL
of	NULL
OCA-B	NULL
in	NULL
a	NULL
reconstituted	NULL
system	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
possibility	NULL
,	NULL
GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
residues	NULL
171	NULL
to	NULL
256	NULL
of	NULL
either	NULL
wild-type	NULL
OCA-B	NULL
or	NULL
the	NULL
B	NULL
mutant	NULL
protein	NULL
were	NULL
employed	NULL
in	NULL
pull-down	NULL
assays	NULL
to	NULL
search	NULL
for	NULL
a	NULL
nuclear	NULL
extract	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
the	NULL
OCA-B	NULL
activation	NULL
domain	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
the	NULL
immunoblot	NULL
analysis	NULL
of	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
functional	NULL
(	NULL
nonphosphorylated	NULL
)	NULL
form	NULL
of	NULL
PC4	NULL
bound	NULL
to	NULL
a	NULL
wild-type	NULL
OCA-B-GST	NULL
fusion	NULL
protein	NULL
but	NULL
not	NULL
to	NULL
the	NULL
mutant	NULL
B-GST	NULL
fusion	NULL
protein	NULL
(	NULL
or	NULL
GST	NULL
alone	NULL
)	NULL
(	NULL
compare	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
to	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
direct	NULL
role	NULL
for	NULL
PC4	NULL
in	NULL
mediating	NULL
OCA-B	NULL
function	NULL
through	NULL
the	NULL
OCA-B	NULL
activation	NULL
domain	NULL
.	NULL

Purified	NULL
recombinant	NULL
PC4	NULL
bound	NULL
to	NULL
OCA-B	NULL
in	NULL
the	NULL
same	NULL
fashion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
OCA-B-PC4	NULL
interaction	NULL
is	NULL
direct	NULL
.	NULL

A	NULL
redundant	NULL
activity	NULL
for	NULL
PC4	NULL
function	NULL
in	NULL
a	NULL
crude	NULL
system	NULL
.	NULL

Given	NULL
that	NULL
OCA-B	NULL
can	NULL
function	NULL
in	NULL
crude	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
to	NULL
activate	NULL
the	NULL
Ig	NULL
promoters	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
explore	NULL
a	NULL
possible	NULL
role	NULL
of	NULL
PC4	NULL
in	NULL
the	NULL
coactivation	NULL
pathway	NULL
in	NULL
the	NULL
crude	NULL
transcription	NULL
system	NULL
on	NULL
the	NULL
grounds	NULL
that	NULL
it	NULL
may	NULL
contain	NULL
a	NULL
more	NULL
complete	NULL
complement	NULL
of	NULL
nuclear	NULL
factors	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
the	NULL
PC4	NULL
protein	NULL
was	NULL
quantitatively	NULL
removed	NULL
by	NULL
immunodepletion	NULL
from	NULL
a	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
and	NULL
the	NULL
PC4-depleted	NULL
extract	NULL
was	NULL
analyzed	NULL
for	NULL
the	NULL
ability	NULL
to	NULL
transcribe	NULL
the	NULL
Oct-1/O0CA-B-dependent	NULL
IgH	NULL
promoter	NULL
and	NULL
a	NULL
control	NULL
Sp1-	NULL
B-CELL-SPECIFIC	NULL
COACTIVATOR	NULL
OCA-B	NULL
_	NULL
3807	NULL
I	NULL
)	NULL
\\\	NULL
A	NULL
A	NULL
(	NULL
23	NULL
2	NULL
)	NULL
\o	NULL
)	NULL
&	NULL
)	NULL
!	NULL

o	NULL
2	NULL
|	NULL
Tt	NULL
A	NULL
:	NULL
!	NULL

!	NULL

!	NULL

1	NULL
*+	NULL
PCi	NULL
#	NULL
=	NULL
»	NULL
-	NULL
--	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Identification	NULL
of	NULL
PC4	NULL
as	NULL
a	NULL
potential	NULL
downstream	NULL
target	NULL
for	NULL
the	NULL
function	NULL
of	NULL
OCA-B	NULL
.	NULL

The	NULL
rationale	NULL
for	NULL
this	NULL
experiment	NULL
is	NULL
explained	NULL
in	NULL
the	NULL
text	NULL
,	NULL
and	NULL
experimental	NULL
details	NULL
are	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Note	NULL
that	NULL
only	NULL
a	NULL
portion	NULL
(	NULL
residues	NULL
171	NULL
to	NULL
256	NULL
)	NULL
of	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
OCA-B	NULL
and	NULL
the	NULL
B	NULL
mutant	NULL
(	NULL
Mut	NULL
.	NULL
)	NULL

protein	NULL
was	NULL
fused	NULL
to	NULL
GST	NULL
.	NULL

+	NULL
and	NULL
++	NULL
represent	NULL
two	NULL
(	NULL
lower	NULL
and	NULL
higher	NULL
,	NULL
respec-tively	NULL
)	NULL
concentrations	NULL
of	NULL
immobilized	NULL
GST	NULL
or	NULL
GST	NULL
fusions	NULL
.	NULL

Inp	NULL
.	NULL

NE	NULL
,	NULL
input	NULL
nuclear	NULL
extract	NULL
.	NULL

dependent	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
PC4-deficient	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
10	NULL
)	NULL
was	NULL
as	NULL
potent	NULL
as	NULL
the	NULL
mock-depleted	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
in	NULL
transcribing	NULL
both	NULL
templates	NULL
and	NULL
OCA-B	NULL
functioned	NULL
equally	NULL
well	NULL
in	NULL
PC4*	NULL
and	NULL
PCA_	NULL
extracts	NULL
to	NULL
stimulate	NULL
the	NULL
IgH	NULL
promoter	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
to	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
to	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
a	NULL
B-cell	NULL
extract	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
redundant	NULL
activity	NULL
capable	NULL
of	NULL
compensating	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
PCA	NULL
in	NULL
the	NULL
crude	NULL
nuclear	NULL
extract	NULL
.	NULL

Such	NULL
an	NULL
activity	NULL
is	NULL
likely	NULL
missing	NULL
from	NULL
the	NULL
chromatographically	NULL
purified	NULL
USA	NULL
fraction	NULL
,	NULL
&	NULL
Mock-Dep	NULL
.	NULL

-	NULL
PC4-Dep	NULL
.	NULL

§	NULL
g	NULL
HeLa	NULL
NE	NULL
HeLa	NULL
NE	NULL
o	NULL
C	NULL
2	NULL
21	NULL
II	NULL
|	NULL
Poa	NULL
+o	NULL
4	NULL
+	NULL
+	NULL
OCA-B	NULL
+	NULL
+	NULL
+	NULL
+	NULL
2XSp1	NULL
igh	NULL
-	NULL
»	NULL
‘	NULL
.	NULL

’	NULL
“	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

PC4	NULL
depletion	NULL
(	NULL
Dep	NULL
.	NULL
)	NULL

from	NULL
a	NULL
nuclear	NULL
extract	NULL
(	NULL
NE	NULL
)	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
transcription	NULL
of	NULL
either	NULL
octamer/Oct-dependent	NULL
(	NULL
IgH	NULL
)	NULL
or	NULL
-independent	NULL
(	NULL
2	NULL
%	NULL
Sp1	NULL
)	NULL
promoters	NULL
,	NULL
suggesting	NULL
a	NULL
potential	NULL
redundant	NULL
activity	NULL
for	NULL
PC4	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
.	NULL

Untreated	NULL
HeLa	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
Namalwa	NULL
(	NULL
B	NULL
cell	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
mock-depleted	NULL
HeLa	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
,	NULL
and	NULL
PC4-depleted	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
to	NULL
transcribe	NULL
the	NULL
promoters	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
PC4	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
and/or	NULL
OCA-B	NULL
(	NULL
20	NULL
ng	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

While	NULL
the	NULL
transcription	NULL
level	NULL
of	NULL
the	NULL
control	NULL
template	NULL
(	NULL
2XSp1	NULL
)	NULL
is	NULL
constant	NULL
in	NULL
all	NULL
lanes	NULL
,	NULL
the	NULL
IgH	NULL
promoter	NULL
responds	NULL
to	NULL
OCA-B	NULL
in	NULL
either	NULL
mock-depleted	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
versus	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
PC4-depleted	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
versus	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
to	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
B-cell	NULL
extract	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
and	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
to	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
control	NULL
template	NULL
(	NULL
2	NULL
%	NULL
Sp1	NULL
)	NULL
is	NULL
described	NULL
in	NULL
reference	NULL
42	NULL
.	NULL

3808	NULL
LUO	NULL
ET	NULL
AL	NULL
.	NULL

making	NULL
PC4	NULL
an	NULL
essential	NULL
component	NULL
for	NULL
the	NULL
function	NULL
of	NULL
Oct-1/0CA-B	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
.	NULL

DISCUSSION	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
targeted	NULL
mutagenesis	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
assays	NULL
,	NULL
has	NULL
been	NULL
used	NULL
to	NULL
define	NULL
domains	NULL
of	NULL
the	NULL
B-cell-specific	NULL
coactivator	NULL
OCA-B	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
its	NULL
proper	NULL
function	NULL
with	NULL
the	NULL
DNA	NULL
binding	NULL
activator	NULL
Oct-1	NULL
.	NULL

Further	NULL
investigations	NULL
aimed	NULL
at	NULL
gaining	NULL
more	NULL
insights	NULL
into	NULL
the	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
OCA-B	NULL
revealed	NULL
a	NULL
synergism	NULL
between	NULL
general	NULL
coactivators	NULL
PC2	NULL
and	NULL
PC4	NULL
in	NULL
mediating	NULL
the	NULL
activation	NULL
or	NULL
coactivation	NULL
by	NULL
Oct-1/0CA-B	NULL
and	NULL
an	NULL
OCA-B-PC4	NULL
interaction	NULL
that	NULL
is	NULL
of	NULL
apparent	NULL
functional	NULL
relevance	NULL
.	NULL

Finally	NULL
,	NULL
studies	NULL
with	NULL
less	NULL
purified	NULL
systems	NULL
revealed	NULL
a	NULL
functional	NULL
redundancy	NULL
in	NULL
general	NULL
coactivators	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
studies	NULL
lead	NULL
to	NULL
a	NULL
refined	NULL
model	NULL
of	NULL
Oct-1/0CA-B	NULL
function	NULL
that	NULL
appears	NULL
to	NULL
parallel	NULL
that	NULL
of	NULL
some	NULL
viral	NULL
coactivators	NULL
.	NULL

OCA-B	NULL
domains	NULL
for	NULL
recruitment	NULL
to	NULL
the	NULL
promoter	NULL
.	NULL

An	NULL
N-terminal	NULL
OCA-B	NULL
domain	NULL
that	NULL
shares	NULL
weak	NULL
similarity	NULL
with	NULL
an	NULL
E1A	NULL
region	NULL
was	NULL
implicated	NULL
in	NULL
Ig	NULL
promoter	NULL
targeting	NULL
through	NULL
interaction	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

However	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
OCA-B	NULL
contacts	NULL
surfaces	NULL
of	NULL
both	NULL
the	NULL
POU-specific	NULL
and	NULL
POU-homeo	NULL
subdomains	NULL
of	NULL
Oct-1	NULL
(	NULL
2	NULL
,	NULL
28	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
nucleotides	NULL
in	NULL
the	NULL
octamer	NULL
element	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
several	NULL
determinants	NULL
in	NULL
OCA-B	NULL
may	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
form	NULL
a	NULL
stable	NULL
DNA-activator-coactivator	NULL
ternary	NULL
complex	NULL
.	NULL

Supporting	NULL
this	NULL
notion	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
several	NULL
OCA-B	NULL
residues	NULL
in	NULL
a	NULL
region	NULL
about	NULL
20	NULL
aa	NULL
C	NULL
terminal	NULL
to	NULL
domain	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
ternary	NULL
complex	NULL
formation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
Oct-1	NULL
POU	NULL
-specific	NULL
and	NULL
POU-homeo	NULL
subdomains	NULL
contact	NULL
opposite	NULL
sides	NULL
of	NULL
the	NULL
DNA	NULL
double	NULL
helix	NULL
(	NULL
20	NULL
)	NULL
,	NULL
the	NULL
octamer-POU-1-OCA-B	NULL
ternary	NULL
complex	NULL
may	NULL
form	NULL
a	NULL
highly	NULL
stable	NULL
ringlike	NULL
structure	NULL
important	NULL
for	NULL
high	NULL
level	NULL
,	NULL
long-term	NULL
Ig	NULL
promoter-en-hancer	NULL
function	NULL
in	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

An	NULL
OCA-B	NULL
domain	NULL
involved	NULL
in	NULL
promoter	NULL
activation	NULL
and	NULL
general	NULL
coactivator	NULL
requirements	NULL
for	NULL
its	NULL
function	NULL
.	NULL

The	NULL
acidic	NULL
OCA-B	NULL
region	NULL
(	NULL
domain	NULL
B	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
coactivator	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
B	NULL
)	NULL
but	NULL
not	NULL
for	NULL
binding	NULL
to	NULL
Oct-1	NULL
or	NULL
an	NULL
Oct-1-DNA	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Further	NULL
confirming	NULL
this	NULL
notion	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
while	NULL
a	NULL
Gal4	NULL
(	NULL
1-94	NULL
)	NULL
-OCA-B	NULL
fusion	NULL
protein	NULL
functions	NULL
as	NULL
an	NULL
activator	NULL
on	NULL
promoters	NULL
containing	NULL
Gal4	NULL
binding	NULL
sites	NULL
(	NULL
13	NULL
,	NULL
53	NULL
)	NULL
,	NULL
a	NULL
mutant	NULL
with	NULL
a	NULL
deletion	NULL
encompassing	NULL
domain	NULL
B	NULL
loses	NULL
the	NULL
activation	NULL
capability	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Protein-protein	NULL
interaction	NULL
assays	NULL
also	NULL
suggest	NULL
that	NULL
domain	NULL
B	NULL
of	NULL
OCA-B	NULL
provides	NULL
a	NULL
determinant	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
the	NULL
general	NULL
coactivator	NULL
PC4	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Given	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
wild-type	NULL
OCA-B	NULL
but	NULL
not	NULL
the	NULL
mutant	NULL
B	NULL
version	NULL
,	NULL
PC4	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
genuine	NULL
downstream	NULL
target	NULL
for	NULL
the	NULL
function	NULL
of	NULL
OCA-B	NULL
.	NULL

This	NULL
is	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
essential	NULL
role	NULL
for	NULL
PC4	NULL
,	NULL
and	NULL
its	NULL
synergism	NULL
with	NULL
general	NULL
coactivator	NULL
PC2	NULL
,	NULL
in	NULL
supporting	NULL
the	NULL
optimal	NULL
function	NULL
of	NULL
Oct-1/OCA-B	NULL
in	NULL
a	NULL
reconstituted	NULL
system	NULL
.	NULL

Since	NULL
PC4	NULL
alone	NULL
is	NULL
as	NULL
potent	NULL
as	NULL
the	NULL
USA	NULL
fraction	NULL
in	NULL
mediating	NULL
the	NULL
function	NULL
of	NULL
Gal4-based	NULL
artificial	NULL
activators	NULL
on	NULL
synthetic	NULL
templates	NULL
with	NULL
multiple	NULL
Gal4-binding	NULL
sites	NULL
in	NULL
the	NULL
same	NULL
reconstituted	NULL
system	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
reference	NULL
11	NULL
)	NULL
,	NULL
the	NULL
PCA-PC2	NULL
synergism	NULL
that	NULL
was	NULL
observed	NULL
for	NULL
the	NULL
function	NULL
of	NULL
Oct-1/0CA¥-B	NULL
may	NULL
reflect	NULL
the	NULL
use	NULL
of	NULL
coactivators	NULL
in	NULL
the	NULL
more	NULL
physiological	NULL
context	NULL
of	NULL
a	NULL
natural	NULL
activator	NULL
and	NULL
promoter	NULL
.	NULL

It	NULL
is	NULL
relevant	NULL
to	NULL
note	NULL
that	NULL
USA	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
a	NULL
crude	NULL
coactivator	NULL
fraction	NULL
capable	NULL
of	NULL
mediating	NULL
high	NULL
levels	NULL
of	NULL
activation	NULL
by	NULL
natural	NULL
activators	NULL
Sp1	NULL
,	NULL
USF	NULL
(	NULL
34	NULL
)	NULL
,	NULL
and	NULL
NFB	NULL
(	NULL
23	NULL
)	NULL
,	NULL
and	NULL
,	NULL
at	NULL
least	NULL
for	NULL
Spl-dependent	NULL
activation	NULL
,	NULL
USA-derived	NULL
fractions	NULL
were	NULL
not	NULL
as	NULL
active	NULL
as	NULL
partially	NULL
purified	NULL
USA	NULL
(	NULL
34	NULL
)	NULL
.	NULL

A	NULL
separate	NULL
study	NULL
(	NULL
9	NULL
)	NULL
also	NULL
has	NULL
shown	NULL
synergism	NULL
between	NULL
PC4	NULL
and	NULL
PC2	NULL
in	NULL
mediating	NULL
ac	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

TATA	NULL
Ig	NULL
Promoter	NULL
‘	NULL
rx	NULL
Mut	NULL
.	NULL

A	NULL
-	NULL
Mut	NULL
.	NULL

B	NULL
\I	NULL
``	NULL
_	NULL
/	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Model	NULL
for	NULL
OCA-B	NULL
function	NULL
.	NULL

Mut	NULL
.	NULL

,	NULL
mutant	NULL
;	NULL
GTF	NULL
,	NULL
general	NULL
transcription	NULL
factors	NULL
;	NULL
ACT	NULL
,	NULL
activation	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
of	NULL
Oct-1	NULL
and	NULL
-2	NULL
;	NULL
Pol	NULL
II	NULL
,	NULL
RNA	NULL
polymerase	NULL
IL	NULL
Asterisks	NULL
denote	NULL
the	NULL
activation	NULL
domains	NULL
in	NULL
either	NULL
OCA-B	NULL
or	NULL
Oct-1	NULL
and	NULL
-2	NULL
.	NULL

The	NULL
dashed	NULL
lines	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
contacting	NULL
residues	NULL
within	NULL
the	NULL
octamer	NULL
motif	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
,	NULL
OCA-B	NULL
may	NULL
also	NULL
contact	NULL
downstream	NULL
sequences	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
a	NULL
footprinting	NULL
assay	NULL
(	NULL
32	NULL
)	NULL
.	NULL

See	NULL
the	NULL
text	NULL
for	NULL
a	NULL
full	NULL
description	NULL
of	NULL
the	NULL
model	NULL
.	NULL

tivation	NULL
by	NULL
thyroid	NULL
hormone	NULL
receptor	NULL
in	NULL
conjunction	NULL
with	NULL
a	NULL
ligand-dependent	NULL
activating	NULL
complex	NULL
.	NULL

A	NULL
model	NULL
for	NULL
Oct-1/OCA-B	NULL
function	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
both	NULL
earlier	NULL
work	NULL
and	NULL
the	NULL
new	NULL
findings	NULL
shown	NULL
here	NULL
,	NULL
we	NULL
present	NULL
a	NULL
refined	NULL
model	NULL
for	NULL
the	NULL
function	NULL
of	NULL
Oct-1/OCA-B	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

OCA-B	NULL
is	NULL
recruited	NULL
to	NULL
the	NULL
target	NULL
Ig	NULL
promoter	NULL
through	NULL
primary	NULL
interaction	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
,	NULL
which	NULL
may	NULL
precede	NULL
Oct-1-DNA	NULL
interactions	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
,	NULL
and	NULL
through	NULL
secondary	NULL
interactions	NULL
with	NULL
DNA	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
.	NULL

In	NULL
conjunction	NULL
with	NULL
Oct-1	NULL
,	NULL
OCA-B	NULL
then	NULL
provides	NULL
an	NULL
activation	NULL
function	NULL
.	NULL

Given	NULL
the	NULL
documented	NULL
physical	NULL
and	NULL
functional	NULL
interaction	NULL
between	NULL
OCA-B	NULL
and	NULL
PC4	NULL
,	NULL
the	NULL
OCA-B	NULL
activation	NULL
domain	NULL
may	NULL
function	NULL
by	NULL
influencing	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
with	NULL
PC4	NULL
as	NULL
an	NULL
adapter	NULL
(	NULL
11	NULL
)	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
the	NULL
defined	NULL
activation	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
(	NULL
ACT	NULL
;	NULL
12	NULL
,	NULL
37	NULL
,	NULL
55	NULL
)	NULL
in	NULL
the	NULL
Oct	NULL
factors	NULL
also	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
promoter	NULL
activation	NULL
because	NULL
its	NULL
removal	NULL
,	NULL
while	NULL
not	NULL
abrogating	NULL
the	NULL
OCA-B	NULL
recruitment	NULL
,	NULL
is	NULL
detrimental	NULL
for	NULL
OCA-B	NULL
coactivation	NULL
(	NULL
31	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
synergism	NULL
between	NULL
the	NULL
activation	NULL
domain	NULL
in	NULL
OCA-B	NULL
and	NULL
that	NULL
in	NULL
Oct-1	NULL
and	NULL
-2	NULL
.	NULL

This	NULL
synergism	NULL
parallels	NULL
the	NULL
synergism	NULL
between	NULL
PC4	NULL
and	NULL
PCZ2	NULL
that	NULL
is	NULL
required	NULL
for	NULL
the	NULL
proper	NULL
function	NULL
of	NULL
Oct-1/O0CA-B	NULL
in	NULL
the	NULL
reconstituted	NULL
system	NULL
,	NULL
raising	NULL
the	NULL
intriguing	NULL
possibility	NULL
of	NULL
a	NULL
functional	NULL
(	NULL
or	NULL
physical	NULL
)	NULL
interaction	NULL
of	NULL
PCZ	NULL
and	NULL
the	NULL
Oct	NULL
activation	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Since	NULL
PC2	NULL
is	NULL
a	NULL
potent	NULL
but	NULL
less	NULL
well-characterized	NULL
activity	NULL
among	NULL
the	NULL
USA-derived	NULL
coactivators	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
18	NULL
)	NULL
,	NULL
its	NULL
synergism	NULL
with	NULL
PC4	NULL
in	NULL
mediating	NULL
the	NULL
function	NULL
of	NULL
OCA-B/Oct-1	NULL
may	NULL
provide	NULL
a	NULL
useful	NULL
assay	NULL
for	NULL
its	NULL
further	NULL
characterization	NULL
.	NULL

A	NULL
redundant	NULL
activity	NULL
(	NULL
X	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
is	NULL
also	NULL
implied	NULL
by	NULL
the	NULL
PC4	NULL
depletion	NULL
analysis	NULL
in	NULL
crude	NULL
extracts	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
model	NULL
also	NULL
indicates	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
loss	NULL
of	NULL
function	NULL
of	NULL
the	NULL
OCA-B	NULL
A	NULL
(	NULL
deficiency	NULL
in	NULL
interaction	NULL
with	NULL
Oct-1	NULL
and	NULL
-2	NULL
)	NULL
and	NULL
B	NULL
(	NULL
deficiency	NULL
in	NULL
interaction	NULL
with	NULL
PC4	NULL
,	NULL
and	NULL
potentially	NULL
the	NULL
redundant	NULL
activity	NULL
[	NULL
X	NULL
]	NULL
,	NULL
that	NULL
also	NULL
leads	NULL
to	NULL
a	NULL
dominant	NULL
negative	NULL
phenotype	NULL
)	NULL
mutant	NULL
proteins	NULL
.	NULL

Functional	NULL
analogy	NULL
of	NULL
OCA-B	NULL
to	NULL
viral	NULL
coactivators	NULL
.	NULL

By	NULL
several	NULL
criteria	NULL
,	NULL
OCA-B	NULL
is	NULL
a	NULL
cellular	NULL
counterpart	NULL
of	NULL
at	NULL
least	NULL
two	NULL
viral	NULL
coactivators	NULL
,	NULL
namely	NULL
,	NULL
the	NULL
adenovirus	NULL
E1A	NULL
and	NULL
HSV	NULL
VP16	NULL
proteins	NULL
.	NULL

E1A	NULL
is	NULL
a	NULL
promiscuous	NULL
coactivator	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
DNA	NULL
binding	NULL
activators	NULL
that	NULL
include	NULL
USF	NULL
,	NULL
Sp1	NULL
,	NULL
the	NULL
ATF	NULL
family	NULL
,	NULL
c-Jun	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
Oct-4	NULL
(	NULL
49	NULL
)	NULL
via	NULL
their	NULL
diverse	NULL
DNA	NULL
binding	NULL
motifs	NULL
and	NULL
thus	NULL
possesses	NULL
the	NULL
potential	NULL
to	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
multiple	NULL
genes	NULL
lacking	NULL
a	NULL
common	NULL
promoter	NULL
element	NULL
.	NULL

Of	NULL
interest	NULL
in	NULL
relation	NULL
to	NULL
OCA-B	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
an	NULL
E1A	NULL
region	NULL
(	NULL
residues	NULL
179	NULL
to	NULL
193	NULL
in	NULL
138	NULL
E1A	NULL
)	NULL
implicated	NULL
in	NULL
promoter	NULL
targeting	NULL
(	NULL
29	NULL
)	NULL
overlaps	NULL
the	NULL
E1A	NULL
region	NULL
(	NULL
residues	NULL
180	NULL
to	NULL
203	NULL
)	NULL
that	NULL
shares	NULL
weak	NULL
sequence	NULL
similarity	NULL
with	NULL
OCA-B	NULL
domain	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
which	NULL
is	NULL
implicated	NULL
in	NULL
Ig	NULL
promoter	NULL
targeting	NULL
through	NULL
interaction	NULL
with	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
Weak	NULL
(	NULL
and	NULL
short	NULL
)	NULL
sequence	NULL
similarity	NULL
notwithstanding	NULL
,	NULL
the	NULL
functional	NULL
analogy	NULL
between	NULL
OCA-B	NULL
and	NULL
E1A	NULL
is	NULL
probably	NULL
best	NULL
exemplified	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
reporter	NULL
genes	NULL
with	NULL
an	NULL
octamer-containing	NULL
enhancer	NULL
in	NULL
embryonal	NULL
carcinoma	NULL
(	NULL
EC	NULL
)	NULL
cells	NULL
(	NULL
49	NULL
)	NULL
.	NULL

First	NULL
,	NULL
in	NULL
differentiated	NULL
EC	NULL
cells	NULL
,	NULL
the	NULL
reporter	NULL
genes	NULL
can	NULL
be	NULL
stimulated	NULL
by	NULL
Oct-4	NULL
(	NULL
also	NULL
named	NULL
Oct-3	NULL
)	NULL
and	NULL
138	NULL
E1A	NULL
in	NULL
a	NULL
synergistic	NULL
fashion	NULL
;	NULL
second	NULL
,	NULL
as	NULL
is	NULL
the	NULL
case	NULL
for	NULL
Oct-1/0O0CA-B	NULL
function	NULL
;	NULL
activation	NULL
domains	NULL
from	NULL
both	NULL
the	NULL
activator	NULL
(	NULL
Oct-4	NULL
)	NULL
and	NULL
the	NULL
coactivator	NULL
(	NULL
ElA	NULL
)	NULL
are	NULL
jointly	NULL
required	NULL
for	NULL
optimal	NULL
enhancer	NULL
function	NULL
;	NULL
third	NULL
,	NULL
Oct-4	NULL
,	NULL
E1A	NULL
,	NULL
and	NULL
octamer	NULL
DNA	NULL
form	NULL
a	NULL
ternary	NULL
complex	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
gel	NULL
shift	NULL
analysis	NULL
;	NULL
finally	NULL
,	NULL
in	NULL
undifferentiated	NULL
EC	NULL
stem	NULL
cells	NULL
,	NULL
a	NULL
high	NULL
level	NULL
of	NULL
activation	NULL
can	NULL
be	NULL
achieved	NULL
by	NULL
endogenous	NULL
Oct-4	NULL
alone	NULL
.	NULL

Given	NULL
all	NULL
of	NULL
these	NULL
par-allels	NULL
,	NULL
it	NULL
is	NULL
reasonable	NULL
to	NULL
postulate	NULL
that	NULL
Oct-4	NULL
functions	NULL
in	NULL
undifferentiated	NULL
EC	NULL
stem	NULL
cells	NULL
with	NULL
an	NULL
E1A	NULL
functional	NULL
ho-molog	NULL
that	NULL
may	NULL
be	NULL
a	NULL
member	NULL
of	NULL
a	NULL
cellular	NULL
coactivator	NULL
family	NULL
represented	NULL
by	NULL
OCA-B	NULL
.	NULL

OCA-B	NULL
also	NULL
shows	NULL
a	NULL
remarkably	NULL
close	NULL
resemblance	NULL
to	NULL
the	NULL
viral	NULL
coactivator	NULL
VP16	NULL
with	NULL
respect	NULL
to	NULL
both	NULL
interactions	NULL
and	NULL
mechanism	NULL
of	NULL
activation	NULL
.	NULL

VP16	NULL
activates	NULL
HSV	NULL
immediate-early	NULL
genes	NULL
by	NULL
engaging	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
multiprotein-promoter	NULL
complex	NULL
in	NULL
conjunction	NULL
with	NULL
Oct-1	NULL
and	NULL
another	NULL
host	NULL
cell	NULL
factor	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
5	NULL
and	NULL
15	NULL
)	NULL
.	NULL

Like	NULL
OCA-B	NULL
,	NULL
VP16	NULL
interacts	NULL
with	NULL
promoter-bound	NULL
Oct-1	NULL
through	NULL
the	NULL
POU	NULL
domain	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
references	NULL
26	NULL
and	NULL
43	NULL
)	NULL
and	NULL
has	NULL
both	NULL
a	NULL
DNA	NULL
binding	NULL
activity	NULL
contingent	NULL
on	NULL
Oct-1	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
25	NULL
,	NULL
52	NULL
;	NULL
reviewed	NULL
in	NULL
references	NULL
5	NULL
and	NULL
15	NULL
)	NULL
and	NULL
an	NULL
acidic	NULL
activation	NULL
domain	NULL
that	NULL
has	NULL
the	NULL
potential	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
general	NULL
cofactor	NULL
PC4	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
,	NULL
in	NULL
both	NULL
cases	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
activation	NULL
domains	NULL
either	NULL
severely	NULL
weaken	NULL
or	NULL
abolish	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
PC4	NULL
(	NULL
11	NULL
and	NULL
this	NULL
work	NULL
)	NULL
further	NULL
supports	NULL
the	NULL
functional	NULL
relevance	NULL
of	NULL
a	NULL
PC4-activation	NULL
domain	NULL
interaction	NULL
.	NULL

The	NULL
function	NULL
and	NULL
direct	NULL
interaction	NULL
of	NULL
PC4	NULL
with	NULL
several	NULL
defined	NULL
acidic	NULL
activation	NULL
domains	NULL
,	NULL
including	NULL
those	NULL
of	NULL
AH	NULL
,	NULL
IE	NULL
,	NULL
E1A	NULL
,	NULL
VP16	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
OCA-B	NULL
(	NULL
this	NULL
work	NULL
)	NULL
strongly	NULL
argue	NULL
for	NULL
the	NULL
role	NULL
of	NULL
PC4	NULL
as	NULL
an	NULL
adapter	NULL
that	NULL
bridges	NULL
promoter-bound	NULL
transcription	NULL
factors	NULL
and	NULL
cofactors	NULL
to	NULL
the	NULL
basal	NULL
transcriptional	NULL
machinery	NULL
by	NULL
interacting	NULL
with	NULL
TFIIA	NULL
(	NULL
11	NULL
)	NULL
and/or	NULL
RNA	NULL
polymerase	NULL
II	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
given	NULL
the	NULL
recent	NULL
identification	NULL
of	NULL
a	NULL
specialized	NULL
Oct-1	NULL
cofactor	NULL
activity	NULL
involved	NULL
in	NULL
the	NULL
S-phase	NULL
activation	NULL
of	NULL
an	NULL
octamer-dependent	NULL
H2B	NULL
promoter	NULL
(	NULL
32	NULL
)	NULL
,	NULL
it	NULL
is	NULL
probable	NULL
that	NULL
at	NULL
least	NULL
some	NULL
cellular	NULL
genes	NULL
are	NULL
controlled	NULL
by	NULL
gene-specific	NULL
coactivators	NULL
that	NULL
function	NULL
analogously	NULL
to	NULL
viral	NULL
coactivators	NULL
and	NULL
are	NULL
represented	NULL
by	NULL
OCA-B	NULL
.	NULL

Redundancy	NULL
in	NULL
general	NULL
coactivator	NULL
function	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
to	NULL
the	NULL
observation	NULL
that	NULL
PC4	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
Oct-1/	NULL
OCA-B	NULL
function	NULL
in	NULL
a	NULL
reconstituted	NULL
system	NULL
,	NULL
PC4	NULL
is	NULL
dispensable	NULL
for	NULL
the	NULL
function	NULL
of	NULL
Oct-1/0OCA-B	NULL
in	NULL
a	NULL
crude	NULL
(	NULL
nuclear	NULL
extract	NULL
)	NULL
system	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
redundant	NULL
activity	NULL
that	NULL
is	NULL
missing	NULL
in	NULL
the	NULL
purified	NULL
components	NULL
used	NULL
in	NULL
the	NULL
reconstituted	NULL
assay	NULL
system	NULL
.	NULL

This	NULL
redundant	NULL
activity	NULL
(	NULL
X	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
may	NULL
serve	NULL
as	NULL
an	NULL
alternative	NULL
adapter	NULL
capable	NULL
of	NULL
mediating	NULL
the	NULL
OCA-B-general	NULL
transcription	NULL
factor	NULL
interaction	NULL
,	NULL
thus	NULL
bypassing	NULL
the	NULL
requirement	NULL
for	NULL
PC4	NULL
in	NULL
a	NULL
crude	NULL
transcription	NULL
system	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
potential	NULL
candidate	NULL
for	NULL
such	NULL
an	NULL
activity	NULL
has	NULL
been	NULL
detected	NULL
by	NULL
purification	NULL
methods	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Functional	NULL
redundancy	NULL
could	NULL
be	NULL
a	NULL
hallmark	NULL
of	NULL
regulatory	NULL
pathways	NULL
in	NULL
transcription	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
an	NULL
absolute	NULL
requirement	NULL
of	NULL
TATA	NULL
box	NULL
binding	NULL
protein-associated	NULL
factor	NULL
(	NULL
TAFS	NULL
)	NULL
for	NULL
activator	NULL
function	NULL
in	NULL
purified	NULL
reconstituted	NULL
systems	NULL
(	NULL
reviewed	NULL
in	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
reference	NULL
57	NULL
)	NULL
,	NULL
studies	NULL
with	NULL
yeast	NULL
(	NULL
conditional	NULL
knockout	NULL
;	NULL
1	NULL
,	NULL
36	NULL
,	NULL
59	NULL
)	NULL
and	NULL
less-purified	NULL
human	NULL
cell-free	NULL
systems	NULL
(	NULL
40	NULL
)	NULL
challenge	NULL
the	NULL
view	NULL
of	NULL
a	NULL
universal	NULL
role	NULL
of	NULL
TAFs	NULL
in	NULL
promoter	NULL
activation	NULL
and	NULL
imply	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
distinct	NULL
class	NULL
of	NULL
functionally	NULL
redundant	NULL
activities	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
those	NULL
present	NULL
in	NULL
the	NULL
RNA	NULL
polymerase	NULL
II	NULL
holoenzyme	NULL
[	NULL
reviewed	NULL
in	NULL
references	NULL
3	NULL
,	NULL
21	NULL
,	NULL
and	NULL
38	NULL
]	NULL
)	NULL
that	NULL
may	NULL
act	NULL
through	NULL
B-CELL-SPECIFIC	NULL
COACTIVATOR	NULL
OCA-B	NULL
_	NULL
3809	NULL
distinct	NULL
mechanisms	NULL
.	NULL

As	NULL
is	NULL
the	NULL
case	NULL
for	NULL
the	NULL
function	NULL
of	NULL
OCA-B	NULL
,	NULL
this	NULL
implies	NULL
alternative	NULL
pathways	NULL
for	NULL
communication	NULL
between	NULL
activators	NULL
and/or	NULL
coactivators	NULL
and	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
Y.L	NULL
.	NULL

thanks	NULL
M.	NULL
Kretzschmar	NULL
and	NULL
S.	NULL
Malik	NULL
for	NULL
generous	NULL
gifts	NULL
of	NULL
general	NULL
factors	NULL
and	NULL
cofactors	NULL
used	NULL
in	NULL
pilot	NULL
experiments	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Roeder	NULL
laboratory	NULL
for	NULL
encouragement	NULL
and	NULL
stimulating	NULL
discussions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
NIH	NULL
grant	NULL
CA43567	NULL
and	NULL
by	NULL
a	NULL
Johnson	NULL
and	NULL
Johnson	NULL
Focused	NULL
Giving	NULL
Award	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Apone	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
C.	NULL
A.	NULL
Virbasius	NULL
,	NULL
J.	NULL
C.	NULL
Reese	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1996	NULL
.	NULL

Yeast	NULL
TAF,90	NULL
is	NULL
required	NULL
for	NULL
cell-cycle	NULL
progression	NULL
through	NULL
G2/M	NULL
but	NULL
not	NULL
for	NULL
general	NULL
transcription	NULL
activation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:2368-2380	NULL
.	NULL

2	NULL
.	NULL

Babb	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
A.	NULL
Cleary	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1997	NULL
.	NULL

OCA-B	NULL
is	NULL
a	NULL
functional	NULL
analog	NULL
of	NULL
VP16	NULL
but	NULL
targets	NULL
a	NULL
separate	NULL
surface	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:7295-7305	NULL
.	NULL

3	NULL
.	NULL

Bjorlund	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Y.-J	NULL
.	NULL

Kim	NULL
.	NULL

1996	NULL
.	NULL

Mediator	NULL
of	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

21:335-337	NULL
.	NULL

4	NULL
.	NULL

Cepek	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
D.	NULL
I.	NULL
Chasman	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1996	NULL
.	NULL

Sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
B-cell-specific	NULL
coactivator	NULL
OCA-B	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:2079-2088	NULL
.	NULL

5	NULL
.	NULL

Cleary	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
S.	NULL
Stern	NULL
,	NULL
M.	NULL
Tanaka	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
positive	NULL
control	NULL
by	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
transcriptionally	NULL
silent	NULL
motif	NULL
through	NULL
Oct-1	NULL
and	NULL
VP16	NULL
corecruitment	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:72-83	NULL
.	NULL

6	NULL
.	NULL

Corcoran	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
Karvelas	NULL
.	NULL

1994	NULL
.	NULL

Oct-2	NULL
is	NULL
required	NULL
carly	NULL
in	NULL
T	NULL
cell-independent	NULL
B	NULL
cell	NULL
activation	NULL
for	NULL
G1	NULL
progression	NULL
and	NULL
for	NULL
proliferation	NULL
.	NULL

Immunity	NULL
1:635-645	NULL
.	NULL

7	NULL
.	NULL

Corcoran	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Karvelas	NULL
,	NULL
G.	NULL
Nossal	NULL
,	NULL
Z.	NULL
Ye	NULL
,	NULL
T.	NULL
Jacks	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1993	NULL
.	NULL

Oct-2	NULL
,	NULL
although	NULL
not	NULL
required	NULL
for	NULL
early	NULL
B-cell	NULL
development	NULL
,	NULL
is	NULL
critical	NULL
for	NULL
later	NULL
B-cell	NULL
maturation	NULL
and	NULL
for	NULL
postnatal	NULL
survival	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:570-582	NULL
.	NULL

8	NULL
.	NULL

Feldhaus	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Klug	NULL
,	NULL
K.	NULL
Arvin	NULL
,	NULL
and	NULL
H.	NULL
Singh	NULL
.	NULL

1993	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
the	NULL
oct-2	NULL
locus	NULL
in	NULL
a	NULL
B	NULL
cell	NULL
provides	NULL
genetic	NULL
evidence	NULL
for	NULL
two	NULL
distinct	NULL
cell	NULL
type-specific	NULL
pathways	NULL
of	NULL
octamer	NULL
element-mediated	NULL
gene	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2763-2772	NULL
.	NULL

9	NULL
.	NULL

Fondell	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Guermah	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

Unpublished	NULL
observations	NULL
.	NULL

10	NULL
.	NULL

Ge	NULL
,	NULL
H.	NULL
,	NULL
E.	NULL
Martinez	NULL
,	NULL
C.	NULL
M.	NULL
Chiang	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1996	NULL
.	NULL

Activator-dependent	NULL
transcription	NULL
by	NULL
mammalian	NULL
RNA	NULL
polymerase	NULL
II	NULL
:	NULL
in	NULL
vitro	NULL
recon-stitution	NULL
with	NULL
general	NULL
transcription	NULL
factors	NULL
and	NULL
cofactors	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

272:57-71	NULL
.	NULL

11	NULL
.	NULL

Ge	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1994	NULL
.	NULL

Purification	NULL
,	NULL
cloning	NULL
,	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
coactivator	NULL
,	NULL
PC4	NULL
,	NULL
that	NULL
mediates	NULL
transcriptional	NULL
activation	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Cell	NULL
78:513-523	NULL
.	NULL

12	NULL
.	NULL

Gerster	NULL
,	NULL
T.	NULL
,	NULL
C.-G.	NULL
Balmaceda	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
cell	NULL
type-specific	NULL
octamer	NULL
transcription	NULL
factor	NULL
OTF-2	NULL
has	NULL
two	NULL
domains	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1635-1643	NULL
.	NULL

13	NULL
.	NULL

Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Knoepfel	NULL
,	NULL
O.	NULL
Georgiev	NULL
,	NULL
W.	NULL
Schaffner	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Hovens	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
B-cell	NULL
coactivator	NULL
of	NULL
octamer-binding	NULL
transcription	NULL
factors	NULL
.	NULL

Nature	NULL
373:360-362	NULL
.	NULL

14	NULL
.	NULL

Gstaiger	NULL
,	NULL
M.	NULL
,	NULL
O.	NULL
Georgiev	NULL
,	NULL
H.	NULL
van	NULL
Leeuwen	NULL
,	NULL
P.	NULL
van	NULL
der	NULL
Vliet	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
coactivator	NULL
Bob1	NULL
shows	NULL
DNA	NULL
sequence-depen-dent	NULL
complex	NULL
formation	NULL
with	NULL
Oct-1/Oct-2	NULL
factors	NULL
,	NULL
leading	NULL
to	NULL
differential	NULL
promoter	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:2781-2790	NULL
.	NULL

15	NULL
.	NULL

Herr	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Cleary	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
POU	NULL
domain	NULL
:	NULL
versatility	NULL
in	NULL
transcriptional	NULL
regulation	NULL
by	NULL
a	NULL
flexible	NULL
two-in-one	NULL
DNA-binding	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1679-1693	NULL
.	NULL

16	NULL
.	NULL

Herr	NULL
,	NULL
W.	NULL
,	NULL
R.	NULL
A.	NULL
Sturm	NULL
,	NULL
R.	NULL
G.	NULL
Clerc	NULL
,	NULL
L	NULL
M.	NULL
Corcoran	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
H.	NULL
A.	NULL
Ingraham	NULL
,	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
Finney	NULL
,	NULL
G.	NULL
Ruvkun	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Horvitz	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
POU	NULL
domain	NULL
:	NULL
a	NULL
large	NULL
conserved	NULL
region	NULL
in	NULL
the	NULL
mammalian	NULL
pit-1	NULL
,	NULL
oct-1	NULL
,	NULL
oct-2	NULL
,	NULL
and	NULL
Caenorhabditis	NULL
elegans	NULL
unc-86	NULL
gene	NULL
products	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

21513-1516	NULL
.	NULL

17	NULL
.	NULL

Hoffmann	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1991	NULL
.	NULL

Purification	NULL
of	NULL
his-tagged	NULL
proteins	NULL
in	NULL
non-denaturing	NULL
conditions	NULL
suggests	NULL
a	NULL
convenient	NULL
method	NULL
for	NULL
protein	NULL
interaction	NULL
studies	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:6337-6338	NULL
.	NULL

18	NULL
.	NULL

Kaiser	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
M.	NULL
Meisterernst	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
human	NULL
general	NULL
co-factors	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

21:343-345	NULL
.	NULL

19	NULL
.	NULL

Kim	NULL
,	NULL
U.	NULL
,	NULL
X.-F.	NULL
Qin	NULL
,	NULL
S.	NULL
Gong	NULL
,	NULL
S.	NULL
Stevens	NULL
,	NULL
Y.	NULL
Luo	NULL
,	NULL
M.	NULL
C.	NULL
Nussenzweig	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
B-cell-specific	NULL
transcription	NULL
coactivator	NULL
OCA-B/	NULL
OBF-1/Bob-1	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
normal	NULL
production	NULL
of	NULL
immunoglobulin	NULL
isotypes	NULL
.	NULL

Nature	NULL
383:543-547	NULL
.	NULL

20	NULL
.	NULL

Klemm	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
M.	NULL
A.	NULL
Rould	NULL
,	NULL
R.	NULL
Aurora	NULL
,	NULL
W.	NULL
Herr	NULL
,	NULL
and	NULL
C.	NULL
O.	NULL
Pabo	NULL
.	NULL

1994	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain	NULL
bound	NULL
to	NULL
an	NULL
octamer	NULL
site	NULL
:	NULL
DNA	NULL
recognition	NULL
with	NULL
tethered	NULL
DNA	NULL
binding	NULL
modules	NULL
.	NULL

Cell	NULL
77:21-32	NULL
.	NULL

21	NULL
.	NULL

Koleske	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
A	NULL
.	NULL

Young	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
RNA	NULL
polymerase	NULL
II	NULL
holoenzyme	NULL
and	NULL
its	NULL
implications	NULL
for	NULL
gene	NULL
regulation	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20:113-116	NULL
.	NULL

22	NULL
.	NULL

Kretzschmar	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Kaiser	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
and	NULL
M.	NULL
Meisterernst	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
3810	NULL
23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

LUO	NULL
ET	NULL
AL	NULL
.	NULL

novel	NULL
mediator	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
with	NULL
homology	NULL
to	NULL
viral	NULL
imme-diate-carly	NULL
transcriptional	NULL
regulators	NULL
.	NULL

Cell	NULL
78:525-534	NULL
.	NULL

Kretzschmar	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Meisterernst	NULL
,	NULL
C.	NULL
Scheidereit	NULL
,	NULL
G.	NULL
Li	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:761-774	NULL
.	NULL

Kretzschmar	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Stelzer	NULL
,	NULL
R.	NULL
G.	NULL
Roeder	NULL
,	NULL
and	NULL
M.	NULL
Meisterernst	NULL
.	NULL

1994	NULL
.	NULL

RNA	NULL
polymerase	NULL
II	NULL
cofactor	NULL
PC2	NULL
facilitates	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
Gal4-AH	NULL
in	NULL
vitro	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3927-3937.	NULL
.	NULL

Kristie	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1990	NULL
.	NULL

Interactions	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
sub	NULL
domains	NULL
with	NULL
specific	NULL
DNA	NULL
sequences	NULL
and	NULL
with	NULL
the	NULL
HSV	NULL
a	NULL
trans-activator	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:2383-2396	NULL
.	NULL

Lai	NULL
,	NULL
J.-S.	NULL
,	NULL
M.	NULL
A.	NULL
Cleary	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
single	NULL
amino	NULL
acid	NULL
exchange	NULL
transfers	NULL
VP16-induced	NULL
positive	NULL
control	NULL
from	NULL
the	NULL
Oct-1	NULL
to	NULL
the	NULL
Oct-2	NULL
home-odomain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2058-2065	NULL
.	NULL

Landolfi	NULL
,	NULL
N.	NULL
F.	NULL
,	NULL
J.	NULL
D.	NULL
Capra	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Tucker	NULL
.	NULL

1986	NULL
.	NULL

Interaction	NULL
of	NULL
cell-type-specific	NULL
nuclear	NULL
proteins	NULL
with	NULL
immunoglobulin	NULL
VH	NULL
promoter	NULL
region	NULL
sequences	NULL
.	NULL

Nature	NULL
323:548-551	NULL
.	NULL

Li	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Luo	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

Unpublished	NULL
observations	NULL
.	NULL

Liu	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1994	NULL
.	NULL

Promoter	NULL
targeting	NULL
by	NULL
adenovirus	NULL
Ela	NULL
through	NULL
interaction	NULL
with	NULL
different	NULL
cellular	NULL
DNA-binding	NULL
domains	NULL
.	NULL

Nature	NULL
368:520-525	NULL
.	NULL

Luo	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
T.	NULL
Gerster	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
B	NULL
cell-derived	NULL
coactivator	NULL
potentiates	NULL
the	NULL
activation	NULL
of	NULL
immunoglobulin	NULL
promoters	NULL
by	NULL
octamer-binding	NULL
transcription	NULL
factors	NULL
.	NULL

Cell	NULL
71:231-241	NULL
.	NULL

Luo	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
,	NULL
functional	NULL
characterization	NULL
,	NULL
and	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
the	NULL
B-cell-specific	NULL
transcriptional	NULL
coactivator	NULL
OCA-B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:4115-4124	NULL
.	NULL

Luo	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

Unpublished	NULL
observations	NULL
.	NULL

Malik	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Guermah	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
dynamic	NULL
model	NULL
for	NULL
PC4	NULL
coactivator	NULL
function	NULL
in	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:2192-2197	NULL
.	NULL

Meisterernst	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Roy	NULL
,	NULL
H.-M.	NULL
Lieu	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
by	NULL
regulatory	NULL
factors	NULL
is	NULL
potentiated	NULL
by	NULL
a	NULL
novel	NULL
activity	NULL
.	NULL

Cell	NULL
66:981-993	NULL
.	NULL

Mitchell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Science	NULL
245:371-378	NULL
.	NULL

Mogtaderi	NULL
,	NULL
Z.	NULL
,	NULL
Y.	NULL
Bai	NULL
,	NULL
D.	NULL
Poon	NULL
,	NULL
P.	NULL
A.	NULL
Weil	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
.	NULL

1996	NULL
.	NULL

TBP-associated	NULL
factors	NULL
are	NULL
not	NULL
generally	NULL
required	NULL
for	NULL
transcription	NULL
activation	NULL
in	NULL
yeast	NULL
.	NULL

Nature	NULL
383:188-190	NULL
.	NULL

Miiller-Immergliick	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
W.	NULL
Schaffner	NULL
,	NULL
and	NULL
P.	NULL
Matthias	NULL
.	NULL

1990	NULL
.	NULL

Transcription	NULL
factor	NULL
Oct-2A	NULL
contains	NULL
functionally	NULL
redundant	NULL
activating	NULL
domains	NULL
and	NULL
works	NULL
selectively	NULL
from	NULL
a	NULL
promoter	NULL
but	NULL
not	NULL
from	NULL
a	NULL
remote	NULL
enhancer	NULL
position	NULL
in	NULL
non-lymphoid	NULL
(	NULL
HeLa	NULL
)	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1625-1634	NULL
.	NULL

Myers	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
C.	NULL
M.	NULL
Gustafsson	NULL
,	NULL
D.	NULL
A.	NULL
Bushnell	NULL
,	NULL
M.	NULL
Lui	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Kornberg	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
Med	NULL
proteins	NULL
of	NULL
yeast	NULL
and	NULL
their	NULL
function	NULL
through	NULL
the	NULL
RNA	NULL
polymerase	NULL
II	NULL
carboxy-terminal	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1245-54	NULL
.	NULL

Nielsen	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
O.	NULL
Georgiev	NULL
,	NULL
B.	NULL
Lorenz	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1996	NULL
.	NULL

B	NULL
lympho-cytes	NULL
are	NULL
impaired	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcriptional	NULL
co-activator	NULL
Bob1/	NULL
OCA-B/OBF1	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:3214-3218	NULL
.	NULL

Oclgeschliiger	NULL
,	NULL
T.	NULL
,	NULL
Y.	NULL
Tao	NULL
,	NULL
Y.-K.	NULL
Kang	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1998	NULL
.	NULL

Transcription	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

activation	NULL
via	NULL
enhanced	NULL
preinitiation	NULL
complex	NULL
assembly	NULL
in	NULL
a	NULL
human	NULL
cell	NULL
free	NULL
system	NULL
lacking	NULL
Mol	NULL
.	NULL

Cell	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Pierani	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
H.	NULL
Fujii	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
octamer-containing	NULL
promoters	NULL
by	NULL
either	NULL
octamer	NULL
binding	NULL
transcription	NULL
factor	NULL
1	NULL
(	NULL
OTF-1	NULL
)	NULL
or	NULL
OTF-2	NULL
and	NULL
requirement	NULL
of	NULL
an	NULL
additional	NULL
B-cell-specific	NULL
component	NULL
for	NULL
optimal	NULL
transcription	NULL
of	NULL
immunoglobulin	NULL
promoters	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6204-6215	NULL
.	NULL

Pognonec	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1991	NULL
.	NULL

Recombinant	NULL
43-kDa	NULL
USF	NULL
binds	NULL
to	NULL
DNA	NULL
and	NULL
activates	NULL
transcription	NULL
in	NULL
a	NULL
manner	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
natural	NULL
43/44-kDa	NULL
USF	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5125-5136	NULL
.	NULL

Pomerantz	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
T.	NULL
M.	NULL
Kristie	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

Recognition	NULL
of	NULL
the	NULL
surface	NULL
of	NULL
a	NULL
homeo	NULL
domain	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2047-2057	NULL
.	NULL

Roeder	NULL
,	NULL
R.	NULL
G.	NULL
1996	NULL
.	NULL

The	NULL
role	NULL
of	NULL
general	NULL
initiation	NULL
factors	NULL
in	NULL
transcription	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

21:327-335	NULL
.	NULL

Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
1991	NULL
.	NULL

POU-domain	NULL
transcription	NULL
factors	NULL
:	NULL
pou-er-ful	NULL
developmental	NULL
regulators	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:897-907	NULL
.	NULL

Ruvkun	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
M.	NULL
Finney	NULL
.	NULL

1991	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
and	NULL
cell	NULL
identity	NULL
by	NULL
POU	NULL
domain	NULL
proteins	NULL
.	NULL

Cell	NULL
64:475-478	NULL
.	NULL

Ryan	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1997	NULL
.	NULL

POU	NULL
domain	NULL
family	NULL
values	NULL
:	NULL
flexi-bility	NULL
,	NULL
partnership	NULL
,	NULL
and	NULL
developmental	NULL
codes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:1207-1225	NULL
.	NULL

Scholer	NULL
,	NULL
H.	NULL
R.	NULL
1991	NULL
.	NULL

Octamania	NULL
:	NULL
the	NULL
POU	NULL
factors	NULL
in	NULL
murine	NULL
development	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

7:323-328	NULL
.	NULL

Scholer	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
T.	NULL
Ciesiolka	NULL
,	NULL
and	NULL
P.	NULL
Gruss	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
nexus	NULL
between	NULL
Oct-4	NULL
and	NULL
E1A	NULL
:	NULL
implications	NULL
for	NULL
gene	NULL
regulation	NULL
in	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

Cell	NULL
66:291-304	NULL
.	NULL

Schubart	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
A.	NULL
Rolink	NULL
,	NULL
M.	NULL
H.	NULL
Kosco-Vilbois	NULL
,	NULL
F.	NULL
Botteri	NULL
,	NULL
and	NULL
P.	NULL
Mattias	NULL
.	NULL

1996	NULL
.	NULL

B-cell-specific	NULL
coactivator	NULL
OBF-1/0CA-B/Bob-1	NULL
required	NULL
for	NULL
immune	NULL
response	NULL
and	NULL
germinal	NULL
center	NULL
formation	NULL
.	NULL

Nature	NULL
383:538-543	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1991	NULL
.	NULL

Immunoglobulin	NULL
gene	NULL
transcription	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

9:373-398	NULL
.	NULL

Stern	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
herpes	NULL
simplex	NULL
virus	NULL
trans-activator	NULL
VP16	NULL
recognizes	NULL
the	NULL
Oct-1	NULL
homeodomain	NULL
:	NULL
evidence	NULL
for	NULL
a	NULL
homeodomain	NULL
recognition	NULL
subdomain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:2555-2566	NULL
.	NULL

Stevens	NULL
,	NULL
S.	NULL
,	NULL
Y.	NULL
Luo	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

Unpublished	NULL
observations	NULL
.	NULL

Strubin	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
W.	NULL
Newell	NULL
,	NULL
and	NULL
P.	NULL
Mattias	NULL
.	NULL

1995	NULL
.	NULL

OBF-1	NULL
,	NULL
a	NULL
novel	NULL
B	NULL
cell-specific	NULL
coactivator	NULL
that	NULL
stimulates	NULL
immunoglobulin	NULL
promoter	NULL
activity	NULL
through	NULL
association	NULL
with	NULL
octamer-binding	NULL
proteins	NULL
.	NULL

Cell	NULL
80:497-506	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
transcriptional	NULL
activation	NULL
by	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
:	NULL
interdependent	NULL
activation	NULL
domains	NULL
induce	NULL
Oct-2	NULL
phosphor-ylation	NULL
.	NULL

Cell	NULL
60:375-386	NULL
.	NULL

Triezenberg	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
R.	NULL
C.	NULL
Kingsbury	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Mcknight	NULL
.	NULL

1988	NULL
.	NULL

Functional	NULL
dissection	NULL
of	NULL
VP16	NULL
,	NULL
the	NULL
transactivator	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
immediate	NULL
carly	NULL
gene	NULL
expression	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2718-729	NULL
.	NULL

Verrijzer	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1996	NULL
.	NULL

TAFs	NULL
mediate	NULL
transcriptional	NULL
activation	NULL
and	NULL
promoter	NULL
selectivity	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

21:338-343	NULL
.	NULL

Walker	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Hayes	NULL
,	NULL
and	NULL
P.	NULL
O'Hare	NULL
.	NULL

1994	NULL
.	NULL

Site-specific	NULL
conformational	NULL
alteration	NULL
of	NULL
the	NULL
Oct-1	NULL
POU	NULL
domain-DNA	NULL
complex	NULL
as	NULL
the	NULL
basis	NULL
for	NULL
differential	NULL
recognition	NULL
by	NULL
Vmw65	NULL
(	NULL
VP16	NULL
)	NULL
.	NULL

Cell	NULL
79:841-852	NULL
.	NULL

Walker	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
J.	NULL
C.	NULL
Reese	NULL
,	NULL
L	NULL
,	NULL
M.	NULL
Apone	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1996	NULL
.	NULL

Transcription	NULL
activation	NULL
in	NULL
cells	NULL
lacking	NULL
TAFps	NULL
.	NULL

Nature	NULL
383:185-188	NULL
.	NULL

Xiao	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
Luo	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

Unpublished	NULL
observations	NULL
.	NULL

